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 %RQH GHIHFWV DQG ERQH JUDIWLQJ
Bone is a structured composite made up of an organic matrix and a mineral phase
[1]. Bone forms the skeleton to support the human body and plays a pivotal role in
maintaining one’s physical and psychosocial well-being. Although bone tissue
possesses certain capacity to regenerate and remodel, it can be severely damaged
by trauma, fractures, or congenital disorders. Every year millions of patients
worldwide sustain bone defects and disorders, which lead to one of the most critical
public health issues in the world [2] [3]. Therefore, bone reconstructive procedures
by using bone grafts or bone substitutes are necessary to repair bone defects.
Despite that autograft is still considered as the gold standard by many orthopedic
surgeons for bone grafting due to its osteogenic, osteoconductive and
osteoinductive capacity [3-5], the associated disadvantages, such as donor limit
and reimplantation injury, limit its clinical application [6]. Allograft is another option
for bone grafting, but risks of disease transfer and immunogenicity also hinder its
clinical use [7-10]. Consequently, there is an increasing need for artificial bone graft
substitutes. In particular, development of the bone substitutes for craniofacial repair
or reconstruction is challenging as the bone in this area shows a morphologically
complex structure [8, 11, 12]; therefore, injectable bone substitutes (IBSs) are
attractive as they offer apparent advantages. For instance, IBSs are ideally to be
used in minimally invasive surgical procedures, and effectively fit the irregular
shaped bone defect in the craniofacial region [13-15]. The application of IBSs may
alleviate patients’ discomfort and reduce the recovery time as well as the treatment
cost [16].
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 300$ IRU ERQH JUDIWLQJ
Polymethylmethacrylate (PMMA) bone cement is the most common type of IBS. It is
applied for filling bone defects, particularly in arthroplasty, vertebroplasty surgeries
and screw augmentation. PMMA is not only a FDA-approved material at a low price,
but also has desirable characteristics, e.g. sufficient strength to provide mechanical
support and moldability to fill complex defects [17-20]. According to a recent survey,
PMMA was used in around 65% of primary total hip joint replacements in Sweden
and 80% of total knee joint replacements in the United States [21], indicating that
PMMA is an irreplaceable material in orthopedic surgery. However, long-term
clinical observations have indicated that PMMA cement is also beset with some
drawbacks [22-24], such as bio-inertness, inappropriate stiffness, high
polymerization temperature, aseptic loosening and lack of anti-bacterial property. As
a consequence, the modification of PMMA has attracted a lot of research interest in
recent years.
 0RGLILFDWLRQV RI 300$ IRU ERQH JUDIWLQJ
In literature, two appealing strategies have been used to modify PMMA cement. The
first strategy involves the incorporation of functional additives into dense PMMA to
improve the performance of PMMA. For instance, the addition of bioceramic
additives such as calcium phosphate (CaP) has been used to improve bioactivity;
Titania-based fibers or rubber fibers were added in PMMA to modify mechanical
properties; Antibiotic agents were mixed in PMMA to prevent or treat infections. The
second strategy is the introduction of open porosity into the dense PMMA to
establish the anchorage at bone/ PMMA interface and balance the mechanical
property of bulk PMMA cement [25-27]. Although a long-term study confirmed the
occurrence of bone ingrowth into the porous PMMA, the bone did not penetrate
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deep into the porosity [28]. Additional animal studies revealed that the porous
PMMA surface was covered by a fibrous tissue capsule, which had an unfavorable
effect on bone ingrowth [20, 22, 29, 30].
 2EMHFWLYH RI WKLV VWXG\
The ultimate goal of PMMA modification is to establish a porous PMMA scaffold to
encourage the deep bone ingrowth as well as to load functional additives to improve
the overall performance of the cement. This thesis focuses on the development of a
porous PMMA with CaP particles as an additive. Specifically, the following research
questions were covered:
1. What is the current state-of-the-art with respect to the modifications of PMMA
for its potential application in orthopedic surgery? (Chapter 2)
2. Can CaP particle be loaded into porous PMMA to improve its physicochemical
property and potential bioactivity for bone osteoconductivity? (Chapter 3)
3. Does the size of CaP particle affect the bulk physicochemical properties and
potential bioactivity of porous PMMA cement? (Chapter 4)
4. Does the amount of CaP particle and pore generator affect the bulk
physicochemical properties and potential bioactivity of porous PMMA cement?
(Chapter 5)
5. What is the bone and tissue response of porous PMMA loaded with CaP?
(Chapter 6)
6. Can different additives be load to establish multifunctional cement based on
porous PMMA and CaP? (Chapter 7)
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$EVWUDFW
Even with the emerging of newly-developed bone substitutes, poly(methyl
methacrylate) (PMMA) cement is still a widely-used bone replacing biomaterial in
orthopedic surgery with a long history. However, aseptic loosening, infection of the
prosthesis and thermal necrosis to surrounding tissue are the common
complications of PMMA. Therefore, additives have been incorporated in PMMA
cement to target those problems. This chapter summarizes different additives to
improve the performance of the PMMA cement, i.e.: 1) bioceramic additives; 2) filler
additives; 3) antibacterial additives; 4) porogens; 5) biological agents, and 6) mixed
additives. To improve the biological and mechanical performance of PMMA cement,
mixed additives aiming to fabricate multifunctional PMMA seem the most suitable
choice. Although LQ YLYR animal studies have been conducted, long-term and clinical
studies are still needed to evaluate the modifications of multifunctional PMMA
cement for matching a specific clinical application.
.H\ZRUGV
poly(methyl methacrylate) cement; additive; bioceramic; porogen; antibacterial
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 *HQHUDO LQWURGXFWLRQ DQG KLVWRU\ RI SRO\PHWK\O PHWKDFU\ODWH
300$
 *HQHUDO LQWURGXFWLRQ RI 300$
Undoubtedly, PMMA or PMMA cement is a successful biomaterial in orthopedic
surgery. Even with the emerging of newly-developed bone substitutes, like calcium
phosphate cement (Chow 2001; Ginebra HW DO 2006; Ishikawa 2014; Zhang HW DO
2014), bioglass (Oonishi HW DO 1997; Moore HW DO 2001), and calcium sulfate cement
(Perry HW DO 2005; Yi HW DO 2008; Chen HW DO 2014), PMMA is still a widely used bone
substitute in cemented arthroplasty, vertebroplasty, and osteoporosis fractures due
to its excellent biocompatibility, low cost, easy handling characteristics, sufficient
strength and moldability LQ VLWX (Choi HW DO 2010; Kretlow HW DO 2010; Lopez-Heredia
HW DO 2012; Sa HW DO 2015; Sa HW DO. 2016; Shi HW DO. 2010; Wang HW DO 2016).
According to a recent survey, PMMA was used in around 65% of primary total hip
joint replacements in Sweden and 80% of total knee joint replacements in the
United States (Lewis 2016), indicating that PMMA is an irreplaceable material in
orthopedic surgery.
However, long-term clinical observations have indicated that PMMA cement is also
beset with some drawbacks (Lewis 1997; Lye HW DO 2009). Aseptic loosening,
infection of the prosthesis and thermal necrosis to surrounding tissue are the most
common complications with PMMA in orthopedic applications (Lye HW DO 2009). In
particular, aseptic loosening accounts for almost two-thirds of the revision hip
arthroplasties and one-half of the revision knee arthroplasties (Sundfeldt HW DO
2006). The major cause of aseptic loosening is the lack of ideal biological and
mechanical characteristics of PMMA cement, which results in a weak PMMA-bone
interface (Vallo HW DO 1999; Bettencourt HW DO 2004). Infection of the prosthesis is a
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devastating complication for the patient. Especially in individuals receiving total joint
replacements, the incidence of PMMA infections even increases to 13%
(Moreira-Gonzalez HW DO 2003). Furthermore, the polymerization of PMMA cement
can induce a high exothermic temperature between 67 and 124 °C (Wang HW DO
1995), which causes necrosis of the surrounding tissues and finally results in
prosthesis failure (Li HW DO 2004; Stanczyk and van Rietbergen 2004; Golz HW DO
2010; Lye HW DO 2011). To overcome the aforementioned shortcomings, roughly six
types of additives, were investigated over the last decades to address the problems
of plain PMMA, i.e.: 1) bioceramic additives; 2) filler additives; 3) antibiotic agents; 4)
porogens, 5) biological agents and 6) mixed additives )LJ ). Bioceramic
additives were used to increase the bioactivity of PMMA cement aiming to enhance
the conjunction between cement and the bone. Furthermore, the added bioceramic
particles would also change the bulk mechanical property of the PMMA cement,
which may benefit the load transfer from the PMMA to bone. Therefore, bioceramics
were added to overcome the aseptic loosening of PMMA. Filler additives were
mixed with PMMA matrix to improve the mechanical property of PMMA, which also
showed beneficial effects on overcoming the aseptic loosening of PMMA. Antibiotic
agents were directly added to control the PMMA infection. Porogens were used to
create the porosities in PMMA, which would change the mechanical property of
PMMA cement and encourage the bone ingrowth to avoid the aseptic loosening.
Moreover, porogens were normally hydrogels, which would significantly reduce the
exothermic temperature to prevent the thermal necrosis. Biological agents were
used to increase the biocompatibility of cement, modify the mechanical property
and reduce the polymerization temperature of PMMA cement, which showed
beneficial effects on reducing the risk of aseptic loosening and thermal necrosis.
Mixed additives, the combinations of two or more aforementioned additives, were
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added to PMMA to create the multifunctional cement to fulfill the requirement in the
clinic.
The current chapter summarizes all the above-mentioned additives and aims to
provide information for future PMMA application in orthopedic surgery. First, the
history of PMMA cement is described, followed by a review of the various PMMA
cement additives. Finally, the chapter provides future perspectives for the
optimization of PMMA cement. It has to be emphasized that the review part only
reports about additives related to the aseptic loosening, infection of the prosthesis
and thermal necrosis to the surrounding tissue. The use of additives to reduce other
drawbacks of PMMA, HJ cement shrink and monomer release, were beyond the
scope of this chapter.
)LJ  A schematic diagram showing the relationship between the incorporation of additives into
PMMA cement and the associated clinical problems.
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 +LVWRU\ RI 300$ FHPHQW
The pioneering work of PMMA started as an industrial synthesized acrylic in the
early 1900s. In 1933, the German chemist Dr. Otto Röhm patented a PMMA product
with the trade name Plexiglass. This material was first applied in submarine
periscopes and airplane canopies (Nottrott 2010). The demand and interest for this
material increased enormously during the pre-war and war era. Later, PMMA was
clinically used for hard contact lenses due to its biocompatible behavior, which was
discovered by accident. In World War II pilots got splinters of the PMMA canopy in
their eyes, which showed no inflammatory response. PMMA found also its use in
dentistry as an essential material to manufacture dentures (Saha and Pal 1984;
Arora HW DO 2013). In the 1950s, a British surgeon from the University of Manchester,
Dr. John Charnley, was the first to adapt “dental acrylic” for the cementation of an
orthopedic prosthesis in total hip arthroplasty surgery (Lye HW DO 2009). However,
the initial clinical results were poor because of mechanical and biological reasons
(Kuhn 2005). After material modification, Dr. Charnley developed a new product
called “bone cement” showing improved characteristics. From then on, modern
PMMA bone cement evolved into a new stage, and the use of PMMA bone cement
quickly expanded to the global orthopedic community. Especially after the Food and
Drug Administration (FDA) approved the use of the bone cement technology in the
United States (Arora HW DO 2013).
Commercial PMMA cement is sold as a two-phase compound, consisting of a solid
and a liquid part. The solid phase consists of the polymer, the catalyst of the
polymerization reaction and the radio-opacifier, whereas the liquid phase is a
mixture of the monomer, the reaction accelerator, and the stabilizer (Magnan HW DO
2013; Saleh HW DO 2016). The hardening time for most of the PMMA cements varies
from 10 to 20 min (Crowninshield 2001). In some cases, PMMA hardening lasts for
weeks after implantation (Eden HW DO 2002; Lai HW DO 2013).
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 0RGLILFDWLRQV RI 300$
 %LRFHUDPLF DGGLWLYHV
The lack of bioactivity is one of the main reasons for aseptic loosening. Plain PMMA
is bioinert (de Wijn 1982; Freeman HW DO 1982; Bruens HW DO 2003). Its surface is not
favorable for adhesion, proliferation, and differentiation of osteoblasts (Choi HW DO
2010). Therefore, the fibrous layer forming at the PMMA-bone interface hampers
the formation of a direct bone contact at the bone-PMMA interface, which leads to
aseptic loosening ()LJ ) (Andersson HW DO 1972; Freeman HW DO 1982; Sundfeldt
HW DO 2006). To establish a direct chemical bonding between bone and PMMA
cement, various osteoconductive bioceramics, like hydroxyapatite (HA), Į-tricalcium
phosphate (Į-TCP), bioglass and calcium acetate, have been incorporated in plain
PMMA to enhance the bioactivity of cement. HA is a well-known calcium phosphate
ceramic that resembles bone mineral. Dalby HW DO added HA to PMMA and
investigated the biological response LQ YLWUR. They found that HA increased the
proliferation and alkaline phosphatase (ALP) activity of primary human
osteoblast-like (HOB) cells (Dalby HW DO 1999; Dalby HW DO 2001, Dalby HW DO 2002).
Further, energy dispersive X-ray analysis showed the calcium peak was absent for
the plain PMMA, while present for PMMA/HA. HOB cells were found to adhere
preferentially to HA particles exposed at the cement surface rather than the polymer
matrix for PMMA/HA samples. Additionally, HOB cells appeared to show greater
expression of vinculin adhesion plaques on PMMA/HA compared to PMMA (Dalby
HW DO 1999; Dalby HW DO 2001). An increased HA amount in PMMA led to enhanced
osteoblast adhesion and response (Dalby HW DO 2002)
Itokawa HW DO investigated the osteoconductivity and biocompatibility of HA-PMMA
cement LQ YLYR. HA-PMMA cement was implanted in the cranium of eight full-grown
beagles with HA cement as a control. After 12 months, no inflammatory reaction
was seen in any of the specimens. New bone formed at the interface of the
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HA-PMMA composite and adhered to the surrounding bone. Mixing HA and PMMA
did not interfere with the physicochemical properties of the HA component and the
newly formed bone was always found preferentially to HA particles exposed at the
HA-PMMA composite surface rather than the PMMA, which indicates that the added
HA enhanced osteoconductivity of the cement (Itokawa HW DO 2007). Other
bioceramics, such as Į-TCP, bioglass and calcium acetate, were also investigated
and they showed similar improvement of the PMMA bioactivity as HA additives
(7DEOH ). Fini et al. synthesized composite polymeric matrix (PMMA + Į-TCP) and
evaluated the LQ YLWUR and LQ YLYR biological properties of composite with PMMA as
the comparative material in the control group. The authors found PMMA + Į-TCP
significantly and positively affected osteoblast viability, synthetic activity and
interleukin-6 level as compared to PMMA. Further, the PMMA + Į-TCP implants in
rabbit bone successfully osteointegrated in trabecular and cortical tissue after 12
weeks. D. Arcos HW DO incorporated bioglass into PMMA and found the modified
cement kept the bioactive behavior of the glass. After soaking into SBF,
nanocrystalline HCA layer was formed on the surface of PMMA-bioglass cement
(Arcos HW DO 2001). Sugino, A HW DO. added calcium acetate into PMMA and found
calcium acetate developed the osteoconductivity of PMMA (Sugino HW DO 2008).
Besides the improved bioactivity, the incorporation of bioceramic additives was also
found to influence the bulk mechanical of characteristics of the cement (Table 1).
Vallo HW DO observed that the added HA particles acted as rigid fillers, which
enhanced the fracture resistance and flexural modulus of PMMA (Vallo HW DO 1999).
This favorable effect occurred only when maximally 15 wt% HA was added. Mousa
HW DO reported that the incorporation of bioglass increased significantly the
compressive strength, elastic modulus and fracture toughness of PMMA, but
decreased the tensile strength (Mousa HW DO 2000).
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)LJ  Light micrograph showing PMMA cement implanted in the mandible bone of the rabbit.
The PMMA became surrounded by a thin fibrous capsule, as indicated by the arrows.
 )LOOHUV
The lack of bioactivity is one of the main reasons for aseptic loosening. Plain PMMA
is bioinert (de Wijn 1982; Freeman HW DO 1982; Bruens HW DO 2003). Its surface is not
favorable for adhesion, proliferation, and differentiation of osteoblasts (Choi HW DO
2010). Therefore, the fibrous layer forming at the PMMA-bone interface hampers
the formation of a direct bone contact at the bone-PMMA interface, which leads to
aseptic loosening ()LJ ) (Andersson HW DO 1972; Freeman HW DO 1982; Sundfeldt
HW DO 2006). To establish a direct chemical bonding between bone and PMMA
cement, various osteoconductive bioceramics, like hydroxyapatite (HA), Į-tricalcium
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phosphate (Į-TCP), bioglass and calcium acetate, have been incorporated in plain
PMMA to enhance the bioactivity of cement. HA is a well-known calcium phosphate
ceramic that resembles bone mineral. Dalby HW DO added HA to PMMA and
investigated the biological response LQ YLWUR. They found that HA increased the
proliferation and alkaline phosphatase (ALP) activity of primary human
osteoblast-like (HOB) cells (Dalby HW DO 1999; Dalby HW DO 2001, Dalby HW DO 2002).
Further, energy dispersive X-ray analysis showed the calcium peak was absent for
the plain PMMA, while present for PMMA/HA. HOB cells were found to adhere
preferentially to HA particles exposed at the cement surface rather than the polymer
matrix for PMMA/HA samples. Additionally, HOB cells appeared to show greater
expression of vinculin adhesion plaques on PMMA/HA compared to PMMA (Dalby
HW DO 1999; Dalby HW DO 2001). An increased HA amount in PMMA led to enhanced
osteoblast adhesion and response (Dalby HW DO 2002)
Itokawa HW DO investigated the osteoconductivity and biocompatibility of HA-PMMA
cement LQ YLYR. HA-PMMA cement was implanted in the cranium of eight full-grown
beagles with HA cement as a control. After 12 months, no inflammatory reaction
was seen in any of the specimens. New bone formed at the interface of the
HA-PMMA composite and adhered to the surrounding bone. Mixing HA and PMMA
did not interfere with the physicochemical properties of the HA component and the
newly formed bone was always found preferentially to HA particles exposed at the
HA-PMMA composite surface rather than the PMMA, which indicates that the added
HA enhanced osteoconductivity of the cement (Itokawa HW DO 2007). Other
bioceramics, such as Į-TCP, bioglass and calcium acetate, were also investigated
and they showed similar improvement of the PMMA bioactivity as HA additives
(7DEOH ). Fini et al. synthesized composite polymeric matrix (PMMA + Į-TCP) and
evaluated the LQ YLWUR and LQ YLYR biological properties of composite with PMMA as
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the comparative material in the control group. The authors found PMMA + Į-TCP
significantly and positively affected osteoblast viability, synthetic activity and
interleukin-6 level as compared to PMMA. Further, the PMMA + Į-TCP implants in
rabbit bone successfully osteointegrated in trabecular and cortical tissue after 12
weeks. D. Arcos HW DO incorporated bioglass into PMMA and found the modified
cement kept the bioactive behavior of the glass. After soaking into SBF,
nanocrystalline HCA layer was formed on the surface of PMMA-bioglass cement
(Arcos HW DO 2001). Sugino, A HW DO. added calcium acetate into PMMA and found
calcium acetate developed the osteoconductivity of PMMA (Sugino HW DO 2008).
Besides the improved bioactivity, the incorporation of bioceramic additives was also
found to influence the bulk mechanical of characteristics of the cement (Table 1).
Vallo HW DO observed that the added HA particles acted as rigid fillers, which
enhanced the fracture resistance and flexural modulus of PMMA (Vallo HW DO 1999).
This favorable effect occurred only when maximally 15 wt% HA was added. Mousa
HW DO reported that the incorporation of bioglass increased significantly the
compressive strength, elastic modulus and fracture toughness of PMMA, but
decreased the tensile strength (Mousa HW DO 2000).
 $QWLEDFWHULDO DJHQWV
Deep infection is a serious complication of total joint arthroplasty (TJA). According
to literature, periprosthetic joint infection (PJI) is responsible for 16.8% of the
failures of all total knee arthroplasty (TKA) revision surgeries and 14.8% of the
failures of all hip revision surgery (Crawford and Murray 1997; Bozic HW DO 2009;
Bozic HW DO 2010; Wyatt HW DO 2014). Therefore, the use of antibiotic-loaded bone
cement (ABC) for the prophylaxis and treatment of PJI has been documented since
the pioneering work of Buchholz and Engelbrecht, who incorporated antibiotics in
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PMMA in the 1970s (Buchholz and Engelbrecht 1970; Buchholz HW DO 1984). From
then on, numerous antibiotic-impregnated cements were tested and PMMA cement
was found to be a good carrier for the release of antibiotics at the site of infection
(Fontanesi HW DO 1981; Minelli HW DO 2004; Allende HW DO 2009) (7DEOH ). There is
general consensus that the use of ABC is a prophylactic and lowers the deep
infection rate in primary TJA (Lewis 2009; Wang HW DO 2013). Due to these
convincing clinical results, ABCs have become the standard of care in reducing
primary infection and improving the success rate of orthopedic implants in most
parts of the world (Lye HW DO 2009).
Based on the dose level of antibiotics, ABC can be used for treatment as well as
prophylaxis. As a rule, at least 3.6 g of antibiotic per 40 g of PMMA cement is
required for treatment to achieve a sufficient therapeutic level of antibiotics during
their elution from the PMMA cement (Penner HW DO 1996; Jiranek HW DO 2006). In
contrast, prophylaxis requires low doses of antibiotics, which is defined as 1 g of
powdered antibiotic per 40 g of PMMA cement (Jiranek HW DO 2006). Gentamicin
was the first and is still the most common antibiotic incorporated into PMMA cement,
which is based on its broad-spectrum activity, low allergy profile, high water
solubility and superior thermal stability (Webb 2007; Lye HW DO. 2009; Arora HW DO.
2013). Clinical data proved that a significant level of gentamicin is obtained in the
vicinity of the cement, even up to 5.5 years after implantation (Wahlig and
Dingeldein 1980). Other less commonly used antibiotics are cefuroxime,
vancomycin, tobramycin, oxacillin, cefazolin, erythromycin and colistin (7DEOH .
They are used alone or together with gentamicin. It is known that the antibiotic
release from bone cement is a complex process (Lawson HW DO 1990; Penner HW DO
1996). Type of antibiotic could affect the elution characteristics of antibiotics. Penner
et al designed three groups of antibiotic loaded PMMA. There were two control
2
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groups, one incorporating vancomycin and the other tobramycin, and one
experimental group in which the two antibiotics were combined. The elution of
tobramycin from the disks in the study group was increased by 68% over that of the
tobramycin control group. The release of vancomycin from the study group disks
was increased by 103% over the vancomycin control group. Combining two
antibiotics in bone-cement improves elution of both antibiotics LQ YLWUR.
Moreover, type of bone cement also influenced the elution effect of antibiotics
(Penner HW DO 1999; Cerretani HW DO 2002). Penner HW DO compared three different
bone cements, namely. Palacos-R, CMW 1, and CMW 3. Vancomycin and
tobramycin were loaded into different cements. During the study period, the cement
disks were placed in saline baths for 9 weeks and the baths were periodically
refreshed. For both antibiotics, there was no significant difference in antibiotic
release between CMW 1 and CMW 3 cement. But the LQ YLWUR elution characteristics
of Palacos-R are superior to CMW1 and CMW2. Cerretani HW DO compare the
elution characteristics of vancomycin alone and in combination with
imipenem-cilastatin from 3 bone-cements (CMW1, Palacos R, and Simplex P). The
cement disks were placed in saline baths for 5 weeks and e baths were periodically
refreshed. Results showed CMW1 had better elution characteristics than the other
cements when treated with vancomycin alone; the elution of Palacos R and Simplex
P were better than that of CMW1 when vancomycin was combined with
imipenem-cilastatin.
Furthermore, the mixing condition would influence the elution effect of antibiotics
(Neut HW DO 2003; Lewis HW DO 2005). As known, the antibiotic is manually blended
with the cement powder at the initial stage of the surgery procedure in the United
States. While in Europe, the antibiotic was blended using an industrial mixer and
pre-packaged for the commercial sell (Lewis HW DO 2005). Lewis et al investigate the
2
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influence of the method of blending gentamicin sulphate with the powder of the
PMMA cement (Lewis HW DO 2005). The blending methods used were manual mixing
(the MANUAL Set), use of small-scale mechanical powder mixer (the
MECHANICAL Set) and use of large-scale industrial mixer (the INDUSTRIAL set). It
was found the elution rates of antibiotic from the MANUAL and the MECHANICAL
Sets were about 36% lower than from the INDUSTRIAL averagely. This finding
showed consistency with the study by Neut et al (Neut HW DO 2003). They
investigated the effect of mixing method of gentamicin powder (manual versus
industrial) with three commercially available PMMA cements. The manual mixing
cement leaded to a lower release of antibiotics than that in corresponding
pre-industrial mixing antibiotic-loaded cements. These results were probably due to
the difference between the distribution of the antibiotic in the cured MANUAL or
MECHANICAL cements and the INDUSTRIAL cements.
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 3RURJHQV
The inclusion of porogens to generate open porosity was considered as an effective
way to improve the inert bone behavior of PMMA (Lye HW DO 2013). The advantage
of introducing porosity in PMMA is that the pores allow the migration of cells, create
sufficient space for nutrient transportation, tissue infiltration, vascularization and
ultimate bone ingrowth. This creates interlocking and anchorage of the PMMA into
the bone and prevents the aseptic loosening (Currey 2001; Bruens HW DO 2003;
Wang HW DO 2013) ()LJ ). Moreover, due to the typical porosity-mechanical
property relationship in materials, the mechanical properties of cement can be
easily tailored by the amount of porogen (Shi HW DO 2010; Shi HW DO 2011; Wang HW DO
2013). Last but not least, porogens, being often water-soluble materials or
hydrogels, can effectively reduce the temperature increase during the PMMA
polymerization by acting as a heat sink.
)LJ  Histological evaluation of bone formation and tissue response to porous poly(methyl
methacrylate) (PMMA) cement in a rabbit mandibular model. The image shows bone ingrowth
within porous PMMA. Black asterisks indicate PMMA component, appearing as empty voids. The
scale bar stands for 1000 mm (Reproduced from Sa Y HW DO, 2017). Reprinted with permission from
TISSUE ENGINEERING: Parts C, May 2017, by Sa Yue, HW DO., published by Mary Ann Liebert, Inc.,
New Rochelle, NY)
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Porous PMMA cement can be produced by mixing the highly viscous, aqueous
biodegradable carboxymethylcellulose (CMC) gel with the hydrophobic PMMA
cement. This method was developed by de Wijn HW DO (de Wijn 1982). The produced
porosity was shown to have a beneficial effect on decreasing the stiffness as well as
polymerization temperature of the PMMA cement. Van Mullem HW DO evaluated the
LQ YLYR biological response of CMC-based porous PMMA cement (van Mullem and
de Wijn 1988; van Mullem HW DO 1988; van Mullem HW DO 1990). They implanted
porous PMMA cement into the frontal and parietal bone of pigs with dense PMMA
cement as control. Cell colonization, blood vessel ingrowth, and bone deposition
were observed within pores. In contrast, the dense PMMA became encapsulated by
connective tissue (van Mullem HW DO 1990). Bruens HW DO evaluated the application
of porous PMMA cement for the correction of human craniofacial defects. The
CT-scan results confirmed that most of the porous PMMA cement specimens
showed calcification at the outer PMMA surface, while one out of four showed
deeper calcifications into the cement at a maximum of 4.5 mm. These results
confirmed the occurrence of bone ingrowth into the porous PMMA. However, it was
also noticed that parts of the porous PMMA showed no calcification at all. This can
be because porous PMMA per se lacks osteoconductivity.
Besides the aforementioned application as bone cement orthopedic devices or
augmentation of cranial defects, porous PMMA was also tested as a temporary
space maintainer for two-stage craniofacial reconstruction. The Mikos’ group
performed a series of LQ YLYR and LQ YLWUR studies for such an application (Kretlow HW
DO 2010; Spicer HW DO 2012; Wang HW DO 2013). In agreement with de Wijn et al (de
Wijn 1982), they observed that porous PMMA decreases maximum polymerization
temperature and reduces compressive strength as well as bending modulus
compared to solid PMMA (Wang HW DO 2013). ,Q YLYR evaluation showed a beneficial
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effect of porous PMMA on soft tissue coverage. In comparison with dense PMMA,
porous PMMA constructs for temporary space maintenance can provide a template
for soft tissue regeneration, priming the wound bed for a definitive repair of the bone
tissue with greater success (Spicer HW DO 2012).
 %LRORJLFDO DJHQW
In addition to the above-mentioned components, biological agents were added to
PMMA cement to increase its bone behavior. Growth hormones are known to play a
central role in the development and growth of skeletal tissues as well as in the
control and local regulation of calcium and phosphorus concentration (Downes HW DO
1990) (Pritchett 1992). Downes HW DO mixed 2.5 mg human Growth Hormone (hGH)
with 10 grams of PMMA to prevent cement loosening. The release of hGH from
PMMA blocks into elution fluid was monitored LQ YLWUR and the hGH-loaded PMMA
was inserted into the femur of rabbit to evaluate the LQ YLYR performance of cement.
The LQ YLWUR release of hGH continued to 40 days, indicating the successful loading
of hGH into PMMA. Histological analysis of the rabbit specimens indicated that after
one month of implantation a greater percentage of osteoid was present at the
hGH-loaded cement surface than at the hGH-free cement. Evidently, the
hGH-loaded cement enhanced the interaction between bone and cement (Downes
HW DO 1990). Pritchett HW DO evaluated the effect of hGH-loaded PMMA in a clinical
study. They mixed 20 mg hGH with 40 grams of PMMA. The hGH-loaded PMMA
and hGH-free PMMA cements were used in 30 patients for hip replacement
treatment (n=15). The levels of hGH secretion were high at the beginning of cement
implantation, but then fell rapidly within the first 72 hours. No complications or
adverse reactions were noted by the addition of hGH (Pritchett 1992). However, the
clinical data could not confirm that hGH-loaded PMMA enhanced the fixation of the
hip prostheses.
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Blood was also used as an additive into PMMA. Ahn HW DO mixed different volumes
of human blood with PMMA (Ahn HW DO 2009). They found that blood reduced
significantly the Young’s modulus of PMMA to that of the osteoporotic vertebral body
and also decreased the polymerization temperature. This effect of blood can decline
the level of stress to the adjacent vertebrae and prevent thermal injury to the nerve
tissue.
 0L[HG DGGLWLYHV
To fulfill the clinical need, frequently two or more additives were combined to create
a multifunctional PMMA composite ()LJ  and 7DEOH ). For example, Arcos HW DO.
mixed bioglass and gentamicin with PMMA. The PMMA/bioglass/gentamicin
composite demonstrated a sustained drug release and a favored the osteogenic
response of bone cell cultures due to the bioglass (Arcos HW DO 2001). However, no
LQ YLYR study was performed to confirm these LQ YLWUR results. He HW DO mixed
bioglass and calcium sulfate (CS) with dense PMMA and investigated the LQ YLWUR
and LQ YLYR reactions of this composite (He HW DO 2012). The bioglass enhanced the
attachment, proliferation and osteogenic differentiation of preosteoblast cells. The
dissolution of CS created porosity on the surface of PMMA, which allowed the
ingrowth of bone in a rabbit femoral condyle model. However, the bone ingrowth
was limited to the surface and bone did not penetrate into the internal structure of
PMMA cement. Therefore, recently a series of novel cements consisting of PMMA,
porogen and functional fillers were fabricated and evaluated. Lopez-Heredia et al
(Lopez-Heredia HW DO 2012) and Sa HW DO (Sa HW DO 2015; Sa HW DO 2016; Sa HW DO
2017) fabricated PMMA/CMC porogen/CaP cement. The CMC hydrogel acted
successfully as a porogen, which decreased the Tmax during cement polymerization
and adjusted the mechanical properties of cement close to the cancellous bone.
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The added CaP increased the biomineralization ability of PMMA cement.
Furthermore, an LQ YLYR study showed that after 12 weeks of PMMA/CMC
porogen/HA implantation, the majority of the porosity was filled with newly formed
bone. The presence of HA in the PMMA enhanced bone formation and bone was
always in direct contact with the HA particles. Shi HW DO mixed colistin with CMC
porogen. The modified PMMA/CMC/colistin showed proper mechanical
characteristics and a safe Tmax. The cement released colistin even up to 5 weeks LQ
YLWUR. Inspired by the PMMA/CMC porogen approach, Shi HW DO (Shi HW DO 2011), Sa
HW DO. (Sa HW DO 2015) and Wang HW DO. (Wang HW DO. 2016) fabricated gelatin hydrogel
or CS based thermo-sensitive hydrogel (CS-GP and CS-PVA hydrogel) as porogens
and these porogens meantime load antibiotic or nano-HA for multifunctional
properties ()LJ ). It was found that interconnected porous structures were
created by the porogens. Porogens and the loading nano-HA particle and antibiotics
produced multifunctional PMMA cements with the proper mechanical property, safe
Tmax, prolonged working time, increased mineralization capacity and enhanced
anti-bacterial activity. However, data are from LQ YLWUR studies and more animal
studies with these multifunctional PMMA cements have still to be performed.
)LJ  Schematic diagram for the preparation of porous as well as multifunctional porous PMMA.
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)LJ To improve the performance of PMMA, artificial extracellular matrices like
chitosan–glycerophosphate (CS–GP) thermosensitive hydrogel and osteoconductive nano-sized
hydroxyapatite (nano-HA)/antibiotic gentamicin (GM) were introduced into PMMA. CS–GP
effectively created open pores at the surface of the PMMA cement and the obtained cement had a
proper modulus of elasticity and a compressive yield strength. Furthermore, the incorporated
nano-HA particles sufficiently increased the mineralization capacity of the cement without
compromising its mechanical properties and the incorporated GM remarkably enhanced the
anti-bacterial activity of the cement. (Reproduced from Graphical Abstract of Sa Y et al, 2015)
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&RQFOXVLRQDQG)XWXUHSHUVSHFWLYHV
Several recentlydevelopedbonecementsareavailable inorthopedicsurgery,but
the application of PMMA-based cement in arthroplasty, vertebral augmentation
proceduresandbonefillingtreatmentaftertumorresectionhasstillamajorimpact
onorthopedicsurgery.PMMAcement isahighlyflexiblebiomaterialwithdesirable
characteristics,i.e.sufficientlystrongtoprovidemechanicalsupport,moldabletofill
complex defects, cost efficient, and FDA-approved. Although the drawbacks
associatedwithMMAcementcancauseclinicalcomplications,theuseofadditives,
such as bioceramics, fillers, antibiotics, porogens and biological agents, can
produceamaterialwithmuchmore favorable properties.The beneficialeffectof
porousPMMAcement on bone ingrowth, drug release and as spacemaintainer
havealreadybeenprovedinthefieldofreconstructivesurgery.
Therefore, more attention should be paid to design PMMA based cement with
added functionality. An elaborated and improved selection of porogens and
functional additives will further enhance the targeted function of porous PMMA
basedcement.Byallmeans, long-term,prospective,multicenterand randomized
clinical trials have to be performed to confirm the favorable effect of these
multifunctionalPMMAcements.
$FNQRZOHGJHPHQWV
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$EVWUDFW
Polymethylmethacrylate (PMMA) cements are amply used in spinal surgery.
Nevertheless, these types of cements present some documented drawbacks.
Therefore, efforts are made to improve the properties and biological performance of
solid PMMA. A porous structure would seem to be advantageous for anchoring
purposes. This work studied the bulk physicochemical, mechanical and
interconnectivity properties of porous PMMA cements loaded with several
percentages of calcium phosphate (CaP). As a measure of bioactivity, changes of
PMMA cements under simulated physiological conditions were studied in a calcium
phosphate solution for 0, 3, 7, 14, 21 and 28 days. Scanning electron microscopy
(SEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR),
micro-computed tomography (μ-CT) and mechanical compression tests were
performed to characterize the morphology, crystallographic and chemical
composition, interconnectivity and mechanical properties, respectively. SEM
allowed observing the result of loading CaP into the porous PMMA, which was
corroborated by XRD, FTIR and μ-CT. No interference of the CaP with the PMMA
was detected. μ-CT described similar interconnectivity and pore distribution for all
CaP percentages. Mechanical properties were not significantly altered by the CaP
percentages or the immersion time. Hence, porous PMMA was effectively loaded
with CaP, which provided the material with properties for potential osteoconductivity.
.H\ZRUGV
Porous Polymethylmethacrylate;Calcium phosphate;Cement;Interconnectivity;
Bioactivity
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 ,QWURGXFWLRQ
Polymethylmethacrylate (PMMA) is a non-adhesive acrylic polymer that is amply
used in orthopedics as bone cement for implants and as vertebral filling material for
spinal surgery, LH vertebroplasty and kyphoplasty [1, 2]. The orthopedical use of
PMMA cement was introduced in the early 1960s by Charnley and this was the first
cement used for spine applications [3]. PMMA has been widely investigated as
bone cement for over 40 years and many injectable PMMA cement formulations
designed for vertebral body applications are commercially available [4, 5]. Tracking
the material during vertebral filling is important to avoid leakage of the material
which increases the risk of injuries or adverse effects [6-8]. Therefore, PMMA
cements can possess radiopaque properties when loaded with Zirconia, Barium
sulfate, Iodine, Tantalum or Tungsten [9, 10]. Reported drawbacks with PMMA are
poor integration with bone, high exothermic polymerization reaction and monomer
toxicity [11-14]. Although Braunstein HW DO. [15] recently reported one rare case were
a significant callus was formed around solid PMMA after an implantation period of
3.5 years in a patient, this publication also indicates that additional factors such as
biphosphonates intake, the possibility of bone stimulation due to a microfracture
environment and space between bone and PMMA need to be considered. As a
result, PMMA SHU VH does not present ideal mechanical and biological
characteristics for long LQ YLYR performance and the bone-PMMA interface may be
the weak link causing occurrence of adjacent level fractures after spinal
augmentation, where the main mechanical mode of loading/deformation is
compression [16, 17]. The human cortical bone presents compressive and elastic
modulus values around 130-180 MPa and 12 GPa, respectively, while the
cancellous bone presents values around 4-12 MPa with an elastic modulus around
81 MPa [18, 19]. Lower mechanical values for PMMA cements are suitable to avoid
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this type of fractures.
Studies of the last decades with PMMA indicate that better materials for spinal bone
filling applications must be found [1, 5]. Hence, continuous attempts for modifying
the characteristics of PMMA to enhance its properties have been made. Calcium
phosphates (CaP) materials can be resorbed and transformed into new bone, have
an bioactive and osteoconductive capacity and are inherently radiopaque [2, 20-22].
Hence, CaP has been considered as an appropriate candidate to be added into
PMMA [23, 24]. It has been proven that the inclusion of CaP additives in the acrylic
matrix does not modify the properties of the CaP. CaP maintains its ability to
promote bone ingrowth while the PMMA cements stays stable [25]. However, solid
PMMA loaded with CaP does not present an open porous structure. It is known that
a porous biomaterial has better anchoring properties at its interface when implanted
in bony sites. Porosity is found among the requirements cited for cements used in
vetebroplasty and kyphoplasty [1, 5]. Porous biomaterials allow the growth of tissue
into the open porous structure, which promotes a stable interface [26-28].
Compared with solid PMMA, porous PMMA offers very interesting osteoconductive
properties, improved biocompatibility while presenting better adapted mechanical
values [29, 30]. Contrary to the bioactive materials, such as CaP, which react
chemically with tissues enhancing their biointegration, solid PMMA is considered
biocompatible, LH it is tolerated by the body without adverse reactions, but inert and
there is no induction of any special reaction such as its biointegration [1, 4]. Loading
porous PMMA with CaP may induce the ingrowth of bone across the interface and
offer the possibility of improving the biological fixation. The addition of CaP to
porous PMMA can establish a compromise between the desired mechanical and
biological properties combining the experience of the use of PMMA and the
biological potential of CaP materials, while reducing the stiffness, polymerization
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temperature and potential monomer toxicity [24, 31, 32]. The present study aims to
assess the bulk physicochemical, mechanical and porometrical properties and the
bioactivity capacity of porous PMMA loaded with several percentages of CaP after
immersion in a physiological solution for several time points.
 0DWHULDOV DQG 0HWKRGV
 3RURXV 300$
Porous PMMA cements loaded with CaP were prepared by using a commercially
available two-component -powder & liquid-, PMMA kit (Palavit®55VS; Heraeus,
Germany), sodium carboxymethylcellulose (CMC; Akucell, AkzoNobel, the
Netherlands) and CaP powders consisting of 85 wt% Į-tricalcium phosphate
(Į-TCP; CAM Implants BV, the Netherlands), 10 wt% dicalcium phosphate
anhydrous (DCPA; J.T. Baker Chemical Co, U.S.A.) and 5 wt% precipitated
hydroxyapatite (pHA; Merck, Germany). CaP powders were ball milled (Pulverisette
6; FRITSCH, Germany) at 500 rpm under dry atmospheric conditions in a
sequential milling pathway [33]. Briefly, Į-TCP powders were first milled for 4.5 h
followed by the addition of DCPA and pHA powders and 1 h of further milling. After
sequential milling, the CaP powders present a particle size around 3 μm and a
specific surface area around 5.90 m2/g [33]. In order to create the porous PMMA,
the procedure developed by de Wijn was used [28]. Briefly, 2.1 g of the PMMA kit
powder part, containing 0.19 g of CMC, were mixed with 1 ml of the PMMA kit liquid
part until obtaining of a homogeneous paste. Then, 2.8 ml of water were added and
the whole was mixed again until homogeneity of the paste. Next, when needed, the
CaP powders were added in order to load the porous PMMA paste with CaP and
everything was mixed again. Several percentages of CaP were used and their
values were related to the added amount of CMC, LH 0.19 g, which was considered
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as 100%. The percentages of CaP used were 0 (control, 0 g), 25 (0.048 g), 50
(0.095 g), 100 (0.19 g), 200 (0.38 g) and 400 (0.76g) %. From now on, reference will
be made to these percentages. After mixing, the paste was put in molds to obtain
cylindrical samples. Cylindrical molds had dimensions of 6 mm in diameter by 12
mm in height. After curing overnight, samples were unmolded. All the process was
performed at room temperature, LH § 23 °C.
 &DOFLXP SKRVSKDWH VROXWLRQ
In order to assess the reaction of porous PMMA in physiological conditions, a
calcium phosphate solution (CPS) was used. Table 1 compares the ion
concentration found in the CPS versus that found in human blood plasma [34].
Briefly, CPS was prepared by dissolving given amounts of reagent-grade NaCl,
CaCl2y2H2O and Na2HPO4y2H2O (VWR, Netherlands) in demineralized water. CPS
was buffered to a pH of 7.4 with 1 0 HCl and Tris. Six Porous PMMA cylinders of
each composition were immersed per 50 ml of CPS for periods of 0 (control), 3, 7,
14, 21 and 28 days. Samples were placed in an incubator at 37 °C. The CPS, when
applicable, was refreshed every 7 days.
7DEOH  Ion concentration, in m0 (mmol/L) of the human blood plasma and
the calcium phosphate solution (CPS).
1D . 0J &D &O +&2 +32 62
+XPDQ %ORRG
3ODVPD        
&36        
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0DWHULDOFKDUDFWHUL]DWLRQ
Scanningelectronmicroscopy(SEM;JEOL6310;Japan)wasusedtoanalyzethe
morphology of the porousPMMAafter the different immersion timeperiods.The
compounds present in the porous PMMA cements were analyzed by X-ray
diffraction (XRD;PW3710Philips,TheNetherlands).XRDwasperformedusinga
Cu.Įradiationsourcewithawavelengthof1.5405ǖatavoltageof40kVanda
currentof30mA.Patternswerecollectedforșvaluesof3ºto70ºinacontinuous
modeata rateof1.125° (ș)perminuteandastepsizeof0.015° (ș).Fourier
transforminfraredspectroscopywith(FTIR;Perkin-Elmer1700,England)wasused
tocharacterizethechemicalbondspresentintheporousPMMAcements.Analyses
wereperformedintherangefrom520to4000cm-1witharesolutionof2cm-1.The
sampleswerescanned100 times foreachFTIRmeasurementand thespectrum
acquiredwas theaverageofall thesescans.Micro-computed tomography (μ-CT)
wasusedtoexaminetheporometricalpropertiesoftheporousPMMAsamples.The
interconnectivity of the sampleswith the different amounts ofCaP loadingswas
determined asdescribed previously [35].Briefly, imagesof the cylindricalporous
PMMAsampleswereacquiredwithahigh-resolutionμ-CTscanner(μ-CT;SkyScan
1072,SkyScan,Belgium).Apixelsizeof11μm,withacquiringconditionsof90kV,
67μA,a1mmAlfilterandarotationstepof1.125°perslicewereused.NRecon®
(SkyScan,Belgium)softwarewasused to reconstruct theacquired image slices.
Around 900 slices per sample were generated. Reconstructed images were
processedwith CTAn® software (SkyScan, Belgium).A custom processing was
appliedtotheregionsofinterest(ROIs)ofthesamplesfittingtheboundaryexactly
(shrink-wrappedboundary).Then,anadaptive thresholdingwasappliedbasedon
localizedanalysisofdensityinordertominimizepartialvolumeeffectandthickness
biasing. Morphometric parameters measured here by CT analysis have been
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previouslyvalidatedwithvirtualobjects,aluminumfoilsandwirephantoms[36,37].
Interconnectivitywasevaluatedbyashrink-wrapprocedure,whichinvolvedmaking
theboundaryoftheROIfollowavolumeofagivenspecificvoxelof0,22,44,88or
176μmandmeasuringthevolumeoccupiedbytheseobjectsincomparisontothe
totalporosityavailable.Analysisofthetotalporosity includedtheclosedandopen
porosity.SEMandμ-CTwereperformedon freeze-driedsamples.XRDandFTIR
analysiswereperformedonsampleswhichwere freeze-driedand thengrounded
byusingamortar.Mechanicalcompressiontestswereperformedbyusingatesting
benchmachine(858MiniBionixII®,MTS,USA).Thecompressiveyieldstrength(ıy)
and the modulus of Elasticity (() were measured at a crosshead speed of
0.5mm/min. Six Porous PMMA cylindrical samples (Q=6) were tested after the
different immersionperiods inCPS, LH0,3,7,14,21and28days,and foreach
loadingpercentageofCaP.Themechanicalpropertiesmeasuredon samples for
the 0-day immersion time period were tested after demolding; for the other
immersiontimeperiods inCPSthemechanicalpropertiesweretestedimmediately
afterbeingtakenoutoftheCPSattheendoftheirrespectiveimmersionperiod.
6WDWLVWLFDODQDO\VLV
Thedatawasstatisticallyanalyzedusingaone-wayANOVAwithaSRVWKRFTukey
test (OriginPro8;Originlab,USA).Resultswereconsideredstatisticallysignificant
atS<0.05
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 5HVXOWV
 0RUSKRORJ\
Fig. 1 displays the bulk morphological features of porous PMMA samples as observed by SEM.
SEM was performed on the cross-section of porous PMMA samples, to avoid an outer region effect.
For the control samples, LH 0% of CaP, where the CMC gel in the freshly prepared samples acted
as pore generator, the CMC remained as a film on the PMMA pore surfaces after drying the
samples for SEM purposes. Porous PMMA samples without immersion displayed a clear increment
of the CaP presence within the CMC film with increasing the CaP amount. At longer immersion
times in CPS, a change in CaP morphology was observed. In the case of the control, the material
showed interaction with the CPS and some formation of CaP-like precipitates (arrows in Fig. 1)
was observed. Such a precipitate was also found for the CaP loaded specimens. However, for high
CaP loading percentages this precipitation effect was harder to distinguish by SEM due to the
presence of the loaded CaP particles.
)LJXUH  SEM images of the cross-section of different porous PMMA cements loaded with different
percentages, LH 0, 50, 100 and 400 %, related to the CMC amount, of CaP powders and after immersion
in CPS at different time points, LH 0, 7, 14 and 28 days. Arrows indicate the precipitates resulting from the
interaction of porous PMMAwith the CPS. Scale bar represents 20 μm.
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 3K\VLFRFKHPLFDO SURSHUWLHV
XRD (Fig. 2) allowed the detection of the CaP compounds present after loading the
porous PMMA. Before immersion only the main component, LH Į-TCP, was
detected around 30.9°. As the immersion period increased, due to the precipitation
from the CPS and the transformation of Į-TCP, an apatitic CaP type with a main
peak around 31.9° was detected. This phase was identified as a calcium deficient
hydroxyapatite (CDHA). As the CaP load increased the presence of Į-TCP became
more evident before immersion and the apatitic CaP type after immersion, LH
CDHA. For the control group, LH without CaP, there was a clear detectable
presence of precipitated CaP after an immersion period of 7 days which confirms an
interaction of the porous PMMA cement with the CPS as was observed by SEM.
FTIR (Fig. 3) presented a less clear tendency than XRD. For percentages lower
than 400% the CaP presence could only be clearly detected after 28 days of
immersion in CPS. In the case of the loaded percentage of 400% CaP, PO43- bands
around 1000 cm-1 are present before immersion and the transformation band of the
loaded CaP, at 960 cm-1, into an apatitic CaP type is detectable after 3 days of
immersion. For the other loaded percentages these CaP bands are not strongly
present. PMMA presented a more complex FTIR spectra composed of several
bands related to the PMMA polymer. FTIR confirmed that the loading of CaP into
the porous PMMA occurred without interfering with the chemical composition of
PMMA. The C=O band at 1725 cm-1 from the polymer matrix did not shift and the
C=C band in the 1638-1645 cm-1 range from residual monomer is not visible in any
of the formulations.
– 63 –
3
524973-L-bw-Sa
Processed on: 12-10-2018 PDF page: 64
)LJXUH  XRD patterns after different immersion time points in CPS for the porous PMMA with
different CaP percentages loaded, LH (a) 0 %, (b) 50 %, (c) 100 % and (d) 400 %, . y = position for
Į-TCP. * = position for the CDHA. a.u. = arbitrary units.
)LJXUH  FTIR spectra after different immersion time points in CPS for different CaP percentages,
LH (a) 0 %, (b) 50 %, (c) 100 % and (d) 400 %, in the porous PMMA. a.u. = arbitrary units. The
arrows at 3d indicate the position of the 960 cm-1 wavelength value.
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 ,QWHUFRQQHFWLYLW\
μCT analysis (Fig. 4) allowed observing that the porous PMMA formulations,
regardless of the loading amount of CaP, had similar structures with irregular porous
shapes. In addition, μ-CT allowed the evaluation of the presence of CaP, which
appeared to be within the porous structure in the PMMA, corroborating SEM
observations. The CaP presence became more evident for a CaP loading
percentages of 200 % or 400 %. Porosity, as measured by μ-CT, was similar for all
samples and had a mean value around 29 %. Interconnectivity analysis confirmed
that porous PMMA cements had an open and highly interconnected porous
structure with a similar behavior, regardless of the amount of CaP. Accessibility of
the open porous structure was high with values between 94% and 74% of the open
pore volume for objects with sizes of 44 μm and for loading percentages of 0% and
400%, respectively. For object sizes around 90 μm and with loading percentages of
0% and 400%, these values were 82% and 56%, respectively. For an object with
size of 176 μm, the interconnectivity decreased down to 50% for 0% of CaP and
down to 15 % for 400 % of CaP. The mean pore size of all the porous PMMA was
similar with a mean value around 230 μm. The pore size distribution also presented
similar tendencies for all porous PMMA samples (Fig. 4d).
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)LJXUH  (a) Representative μ-CT cross-sections of the different porous PMMA loaded with
several percentages of CaP, (b) Percentage of porosity available that is accessible for an object of
a given size in the different porous PMMA with several percentages of CaP, (c) Mean size of the
open porosity for the different porous PMMA with several percentages of CaP and (d) Percentage
distribution (or frequency) of the porosity size regions available on the open porosity present at the
different porous PMMA with several percentages of CaP. The value under the points on Fig. 4d, at
the X-axis, represents the upper limit of the region while the lower limit is the value to its left.
 0HFKDQLFDO SURSHUWLHV
The mechanical properties results are presented in Fig. 5. Results presented a high
variability and a mean ıy value around 8 MPa while for ( the mean value was
around 220 MPa. As a general tendency, it seemed that CaP loading amounts of
200 and 400 % presented more often reduced mean values for compression
strength and modulus of Elasticity, although statistically no significance could be
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determined. Over time, the mechanical properties of the samples did not show
significant changes as well
)LJXUH  Results of the mechanical properties, LH compressive yield strength (ıy) and modulus of
Elasticity (E), for the different porous PMMA loaded with several percentages of CaP and after
immersion in CPS at different time points.
 'LVFXVVLRQ
Due to potential drawbacks in terms of mechanical and biological properties, PMMA
is still not considered as an optimal material for spinal applications. Bioactive
materials have been added to PMMA in order to improve its fixation at bony sites
[38-41]. However, these previous studies have been done in solid PMMA. Porous
scaffolds can solve mechanical related problems [30, 42-44]. Some researchers
have investigated the modification of the mechanical properties of PMMA by
increasing the cement porosity with biodegradable gels [45-47]. Such a technique is
well known by our laboratory and was developed more than 30 years ago [28]. This
method allows having a high interconnectivity at relatively low porosities and a
suitable pore size for bone ingrowth. The previous work performed by GH Wijn and
the work performed by Agis HW DO have shown that CMC does not present an
adverse effect on bone formation [28, 48]. The modified method used here with
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addition of CaP particles to the curing PMMA/CMC mixture was chosen with the
idea to incorporate the CaP in the CMC phase of the porous PMMA. CMC is
immiscible in the PMMA, extractable and responsible for creating the porosity. The
specific CaP powders used were chosen since our laboratory has ample experience
with these materials used as injectable calcium phosphate cements [20, 35, 49].
The present study aimed to assess the bulk physicochemical, mechanical and
porometrical properties, as well as the potential bioactivity of porous PMMA loaded
with several CaP percentages. In order to evaluate these properties in simulate
physiological conditions, porous PMMA samples were immersed in a calcium
phosphate solution and kept in an incubator at 37 °C. This allowed analyzing the
feasibility of loading CaP into porous PMMA, their properties and the enhancement
of bioactivity capability –LH the stimulation of bone ingrowth- LQ YLWUR [50, 51].
Results demonstrated that loading CaP into porous PMMA cements was feasible
and performed without acting negatively on the bulk physicochemical, mechanical
and porometrical properties. CMC presented a given “retention” capacity for the
CaP. Up to loading percentages of 400% a neglectable CaP entrapment in the
PMMA of loose CaP particles occurred. SEM and μ-CT evidenced that most, if not
all, of the CaP was within the porous structure. FTIR demonstrated that there was
no evidence of the polymerization being impaired by the CaP presence. Water
reacted preferentially with CMC to form a gel. The preferential inclusion of CaP in
the CMC hydrogel and thus in the pores, was possible due to the hydrophilic nature
of the CaP particles which are easier wetted by the CMC gel than by the curing
organic PMMA cement [52]. Hence, having the CaP present in the interconnected
pores of the PMMA, allowed it to be available to the surrounding environment. This
availability was observed by SEM, XRD and FTIR, showing the transformation of
the CaP which would not had been possible if the particles were completely covered
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by PMMA. The transformation of this CaP composition has been monitored before
and is in accordance with the present observations [35]. Drying of the samples
created an artifact, LH the formation of a CMC film, which made shifting the CaP
particles to the pore surfaces. SEM and μ-CT identified this artifact. In practice this
would not occur since the CaP particles will be entrapped in the CMC. However, the
fate of the particles due to the leaching/substitution of the CMC LQ YLYR and for long
periods is uncertain and must be studied in future studies in order to optimize the
use of the CaP.
XRD and FTIR indicated that unloaded cements presented a slight capacity to
interact with the CPS but loading CaP enhanced the potential for bone ingrowth as
proven by the transformation of the particles to a more apatitic phase. This
interaction was sustained through longest time point studied here. Moreover, the
interconnected structure of the porous PMMA samples had an appropriate mean
pore size -around 230 μm- for cell invasion and a high accessibility -up to 82%- for
objects with a size around 90 μm which would be an acceptable size for bone
ingrowth. A pore size around 50 μm has been found to be the minimal to allow bone
formation and ingrowth [53, 54]. A minimum volume of 35 wt% of CMC is required in
order to have an interconnected porosity [28]. In our case this percentage was
around 50 wt %.
PMMA SHU VH can reach up to 100 䰂 C, a temperature which is harmful to the
surrounding tissue [14]. The processing of the porous PMMA, CaP-loaded or not,
and its further manipulation with glove-wearing hands did not give a perception of a
temperature higher than the physiological one. These observations agree with
previous ones, in which the addition of CaP to PMMA reduced the MMA
polymerization temperature close to room temperature [55, 56]. In our case, the
CMC aqueous phase and the CaP acted as the heat absorbers for the exothermic
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polymerization of MMA.
The mechanical behavior of solid PMMA loaded with CaP is a complex interaction
of the shape of the CaP, its distribution and amount within the PMMA matrix and the
anisotropy created [39]. In solid PMMA, CaP particles can act either as stress
concentration factors or fracture energy absorbers [40]. Some authors have
reported that adding CaP does not change significantly the mechanical properties
while others report an improvement or a decrease in these [25, 31, 57]. These
differences may be related to the type and size of the CaP and their bonding to the
acrylic matrix. Loading CaP in PMMA strengthened the bone-cement interface due
to the creation of chemical bonds, created a direct contact with bone and caused an
increment of voids [31, 40]. However, the CaP must be available to the surrounding
environment. If in the case of solid PMMA the loaded CaP particles are embedded
in the PMMA matrix without contacting the surrounding tissue, the reason for
including the CaP is useless. The PMMA cements presented here have an even
higher degree of complexity since they form a three-phase system with one-to-two
interactions. However, the process used here is not affected by the CaP in terms of
resulting porosity or interconnectivity of the material since it is done by the CMC.
The process used here defined the interconnectivity as the percentage of the open
porosity accessible to an object of a certain size from the outside. This percentage
depends on the size of the object and on the size of the connections that allow the
access of the object. It has been demonstrated that the mechanical properties of
porous PMMA cements are affected by the porous network and type, size and
amount of the particles included [45, 46]. The method applied here to obtain porous
PMMA does not allow having a specific (round) pore shape but porometrical
parameters can be modified by the amount and viscosity of CMC [28]. Acrylic
cements with lower modulus, like the one used in the present study, are attractive
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since in addition to having a higher interconnected and open porosity - compared to
PMMA alone - with mechanical values closer to those of cancellous bone, they
allow better stress distribution in the filled vertebral body, thus reducing the risk of
fractures on the vertebrae adjacent to the operated sites [16, 17, 28, 46]. Even if
studied by some groups to some extent, the characterization of these cements plus
their pre-clinical use needs further research to find an optimal balance between the
mechanical an biological properties and to fully validate their use [40]. This study
evaluated the bulk physicochemical, mechanical and porometrical properties and
potential bioactivity of porous PMMA cement loaded with CaP, the LQ YLWUR and LQ
YLYR biological aspects of this cement will be assessed in future studies.
 &RQFOXVLRQ
The bioactivity of a material can be enhanced by several factors. The presence of
calcium phosphates (CaP) is one of them. This study demonstrated that porous
PMMA can be loaded with CaP to enhance their bioactivity. Addition of CaP did not
influence the chemical composition and neither the mechanical properties of the
porous PMMA. CMC was responsible for the creation of porosity and
interconnectivity; the addition of CaP did not affect this. When immersed in CPS
under simulated physiological conditions the CaP particles in the porous phase
were available and able to interact with the surrounding environment. These
characteristics make the porous PMMA cement loaded with CaP a promising
candidate for further evaluation in maxillofacial or spinal applications.
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 ,QWURGXFWLRQ
For more than 50 years polymethylmethacrylate (PMMA) cements are most
commonly used for the fixation of prosthetic devices [1, 2]. Other fields of application
include injection of PMMA bone cement into vertebral bodies to prevent or stabilize
osteoporotic fractures or filling of bone defects. Although PMMA has been
extensively applied due to its low cost, easy handling characteristics and moldability
LQ VLWX, PMMA bone cement is associated with several drawbacks. Setting of PMMA
cement proceeds through an exothermic reaction which results into elevated
temperatures, while MMA monomers are toxic. Moreover, PMMA does not bind to
bone and is typically encapsulated by fibrous tissue upon implantation [3-7]. As a
consequence, the cement does not possess the necessary characteristics to
guarantee optimal long-term performance LQ YLYR.
One of the most appealing strategies to improve the biological performance of
PMMA bone cements is to incorporate osteoconductive materials aiming at
enhancing fixation at bony sites. Several studies showed that calcium phosphate
(CaP) ceramics can indeed promote the bonding between bone and cement, but
without improving the amount of bone ingrowth into the bone cement [8, 9]. To
overcome this latter shortcoming, an open porosity is necessary to facilitate bone
tissue ingrowth and improve cement anchorage [10-12]. Studies performed by de
Wijn HW DO and Wang HW DO have shown that a porous PMMA structure can be
produced by mixing a highly viscous, aqueous biodegradable gel, e.g.
carboxymethylcellulose (CMC) as a pore forming phase within the hydrophobic
PMMA cement [7, 13-15]. This porosity was shown to have a beneficial effect on the
bone ingrowth, stiffness and polymerization temperature of PMMA bone cement [5,
10, 16], thereby promoting a stable interface [13, 17]. Consequently, a novel
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strategy to improve the performance of PMMA involves the combination of porous
PMMA bone cement with osteoconductive CaP filler particles. We hypothesized that
porous PMMA containing such CaP particles stimulates bone ingrowth into the
pores and bone apposition onto the surface of osteoconductive CaP particles.
To test this hypothesis, our group focused on the LQ YLWUR and LQ YLYR behavior of
porous PMMA cements loaded with CaP particles [5, 13]. The initial LQ YLWUR
experiment showed that CaP particles could be effectively loaded in the porous
PMMA matrix without influencing the chemical composition of PMMA or the
mechanical properties of the porous cement [13]. To assess the bone and soft
tissue response to these modi¿ed PMMA bone cements, an LQ YLYR animal study
was performed using a mandibular rabbit model [5]. Although porous PMMA-based
cements were biocompatible and supported bone ingrowth and material fixation, the
addition of CaP particles did not increase the amount of bone formation and
ingrowth [5]. We speculated that the physicochemical characteristics of the CaP
particles might influence the final LQ YLYR performance of the modified cements. The
CaP particle used had a size range of 180-425 m which were covered by either
PMMA and/or CMC after dispersion throughout the matrix [5]. CaP particles fully
covered by PMMA matrix can be considered bioinert without contacting the
surrounding tissues, while particles embedded in gel-like CMC might also loosen
resulting into leaking of particles from the pores and triggering the host
inflammatory response. Moreover, the CaP particles used previously were
composed of the ȕ-TCP phase, which is less reactive than Į-TCP but more soluble
and reactive than hydroxyapatite (HA) or biphasic CaP ceramics (ȕ-TCP in
combination with HA) [18, 19]. Since the degradation rate of CaP ceramics strongly
influences the chemical bonding to bone LQ YLYR [20] ȕ-TCP might not be the
suitable CaP phase for loading into porous PMMA scaffolds to provoke the desired
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tissue response.
To further optimize the osteocompatibility of porous PMMA/CaP cements for future
clinical use, the most relevant initial characterization involves LQ YLWUR
characterization of the effect of incorporation of CaP particles on the
physicochemical properties and mineralization capacity of cements. To this end, two
different types of CaP particles were selected in the current study, i.e., micron-sized
reactive CaP particles made of a CaP cement precursor powder and
millimeter-sized passive biphasic CaP particles. Scanning electron microscopy
(SEM) and microcomputed tomography (μ-CT) were used to observe the
morphology of particles and their distribution throughout the porous PMMA scaffold.
Mercury intrusion porosimetry (MIP) was used to analyze the porosity of cements,
while the temperature of the cements was measured using a thermocouple as a
function of setting time. To analyze the mineralization capacity and mechanical
properties of cements LQ YLWUR, the fabricated cements were immersed into simulated
body fluid (SBF) and evaluated by μ-CT, SEM, XRD and mechanical compression
tests at different time points.
 0DWHULDOV DQG 0HWKRGV
 0DWHULDOV
A two-component (powder and liquid) PMMA kit (Self-curing PMMA, type II) was
purchased from Shanghai New Century Dental Materials Co. LTD, Shanghai, China.
The solid component consisted of PMMA powder, dibenzoyl peroxide (BPO)
and silicon dioxide powder. The liquid part was a mixture of methylmetacrylate
(MMA) solution and N, N-dimethyl-p-toluidine (DMPT) solution. BPO was used as
initiator and DMPT was used as accelerator for the polymerization reaction. Sodium
carboxymethylcellulose (99.5% Na-CMC, viscosity (1% solution) 300-500 mPas,
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Akucell AF 2205) was obtained from AkzoNobel, Arnhem, the Netherlands.
Micron-sized reactive CaP particles were composed of a phase mixture of 61%
 -TCP, 26% CaHPO4, 10% CaCO3 and 3% precipitated HA (Calcibon®, Biomet
Merck, Darmstadt, Germany), whereas millimeter-sized passive CaP particles were
made of biphasic CaP (60% ȕ-TCP and 40% HA, CAM Bioceramics BV, Leiden, the
Netherlands). The particle size distribution of these two types of particles was
measured using SEM (JEOL 6340; Japan). At least 50 particles of each type were
observed to obtain the particle size distribution.
 3UHSDUDWLRQ RI SRURXV 300$ DQG FRPSRVLWHV
The raw materials used for the preparation and composition of the bone cement are
listed in 7DEOH . Three groups of porous PMMA based cements were prepared by
following the procedure developed by de Wijn [7]: porous PMMA (pPMMA); porous
PMMA with small, reactive CaP particles (srpPMMA) and porous PMMA with big,
passive CaP particles (bppPMMA). Fabrications were similar as used in our
previous animal study [5]. Briefly, to prepare pPMMA, PMMA phase were manually
formed by mixing PMMA kit powder part and PMMA kit liquid part with the weight
ratio of 2:1 (powder weight to liquid weight). This PMMA phase was concurrently
mixed with equal weight amount of CMC phase (6 wt% CMC in deionized water)
until a homogeneous paste was obtained. Afterwards, the mixture was filled into
Teflon moulds with dimensions of 6 mm in diameter and 12 mm in height to obtain
cylindrical samples. To prepare the particle incorporated samples, CaP powders
with the same weight of PMMA phase was added to the paste, mixed and filled in
the moulds, after which the samples were left to cure at room temperature for 24
hours.
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7DEOH  Weight percentage of compositions in different groups
*URXS
300$PDWUL[  3RUH JHQHUDWRU 
&D3 SDUWLFOHV 
300$ 00$ &0& :DWHU
S300$     í
VUS300$     
ESS300$     
 7KHUPDO SURSHUWLHV
Once the homogeneous mixture was packed into the moulds, the polymerization
temperature was monitored using a type K thermocouple (Testo 925, Lenzkirch,
Germany). The probe of the thermocouple was located at the centre of the sample
surface and the highest temperature (Tmax) during the polymerization reaction was
recorded (n = 3) according to the previous study [5]. All the measurements were
performed at room temperature, i.e., at 23 ºC.
 3RURVLPHWU\
Porous PMMA samples were evaluated by MIP using a Micro-metrics PoroSizer®
9320 mercury intrusion porosimeter. Before the test, samples were freeze-dried
overnight. In total 3 pooled samples of each group were then introduced into the
penetrometer placed in the low-pressure chamber of the porosimeter and filled with
mercury for evaluation. The MIP test was performed at a pressure range between 0
to 170 KPa. The relation between pressure S (MPa) and the pore diameter G (μm)
was determined by the classic Washburn equation [21] on the basis of a model for
cylindrical pores:
݌ ൌ Ͷߛܿ݋ݏߴ݀
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where Ȗ is the surface tension of the mercury and ș is the contact angle between the
mercury and the pore surface of PMMA. In this study, the surface tension and
contact angle of mercury were 0.480 N/m and 140°, respectively [7].
 6%) LPPHUVLRQ
SBF solution was prepared according to the protocol of Kobuko [22]. The
comparison of ion concentrations between SBF and human blood plasma was
shown in 7DEOH . The LQ YLWUR immersion test was carried out by soaking each
sample in 10 ml SBF at 37 °C, which was refreshed weekly. After 7, 14 and 28 days,
samples were washed in deionized water, air-dried and used for the following
studies along with the unsoaked samples as controls.
7DEOH  Ion concentrations, in mM (mmol-1), of SBF and human blood plasma.
1D . 0J &D &O +&2 +32 62
6%)        
+XPDQ EORRG SODVPD        
 0RUSKRORJ\
Micro-computed tomography (μ-CT) was used to examine the particle distribution of
CaP materials upon incorporation into the PMMA matrix. A representative sample
from each group was placed in a custom-made holder to ensure that the long axis of
the sample was oriented perpendicular to the axis of X-ray beam. Scanning was
then performed at 70 kV and 200 mA in high-resolution mode, 1024 reconstruction
matrix, and 400 ms integration time (μ-CT 50, Scanco Medical, Basersdorf,
Switzerland).
SEM (JEOL 6340; Japan) was used to analyze the internal structure of the samples.
SEM was performed on the cross-section of fractured samples which were mounted
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on aluminium stubs using conductive carbon tape and sputter coated with gold
using a JEOL JFC-1200. Subsequently, morphologies of sample were examined at
an accelerating voltage of 10 kV and working distance of 15 mm.
 &KDUDFWHUL]DWLRQ RI &D3 FU\VWDO SKDVH FRPSRVLWLRQ
X-ray diffraction (XRD; PW3710 Philips, The Netherlands) was used to monitor the
phase composition of the CaP particles present in the porous PMMA cements
during SBF immersion. Samples were polished to obtain flat surfaces for XRD
analysis. The analysis was performed using a Cu KĮ radiation source with a
wavelength of 1.5405 ǖ at a voltage of 40 kV and a current of 30 mA. XRD patterns
were collected for 2ڧ values between 10º to 40º in a step mode at a rate of 0.30°
per minute and a step size of 0.01°.
 0HFKDQLFDO SURSHUWLHV
Mechanical compression tests were performed using a tensile bench (810
MiniBionixII®, MTS, USA). In accordance with International Organization for
Standardization Standard ISO5833 (Implants for surgery-acrylic resin cements.
2002) and the previous study [13], 6 mm×12 mm cylindrical constructs (n=3) were
measured to obtain the compressive yield strength (ıy) and the modulus of elasticity
(() at a cross-head speed of 0.5mm/min. Unlike the other tests, the mechanical
properties were performed immediately after soaking in SBF without intermediate
drying of the samples.
 6WDWLVWLFDO DQDO\VLV
The data was statistically analyzed using a one-way ANOVA with a SRVWKRF Tukey
test (SPSS 16.0). Results were considered statistically significant at p < 0.05.
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 5HVXOWV
 3DUWLFOH VL]H
The particle morphologies were shown in )LJ. Small setting particles revealed
particle sizes between 1~30 μm, whereas big non-setting biphasic particles
exhibited particle sizes of between 0.5~1 mm.
)LJ . Scanning electron micrographs of (a) small CaP particles and (b) big biphasic CaP
particles.
 3RO\PHUL]DWLRQ WHPSHUDWXUH
The maximum temperatures during setting of the bone cements Tmax for the
different groups are presented in 7DEOH . During the polymerization reaction, there
was no increase in temperature; Tmax varied from 21.5 - 22.6 °C for all the groups.
Furthermore, the addition of CaP particles had no effect on the Tmax as no significant
difference could be found among all the groups.
7DEOH  Temperature measurement results
Group Tmax (°C) S.D.
pPMMA 22.6 0.2
spPMMA 21.8 0.8
bpPMMA 21.5 1.2
– 86 –
4
524973-L-bw-Sa
Processed on: 12-10-2018 PDF page: 87
7PD[ means the maximum surface temperature during polymerization and S.D
refers to the corresponding standard deviation.
 3RUH SDUDPHWHUV
The porosity with a pore size larger than 10 μm is shown in )LJ D. The porosity for
the pPMMA, srpPMMA and bppPMMA were 29, 23 and 22%, respectively. The pore
size differential curve between 10 to 375 μm obtained by taking the slope of the
pore size distribution curve ()LJ E) showed that the pore sizes within the PMMA
cements decreased in the order: pPMMA > bppPMMA > srpPMMA. The peaks
which represent the average pore diameters corresponded to pore sizes of 140 μm,
63 μm and 45 μm for pPMMA, bppPMMA and srpPMMA, respectively.
)LJ  Porometric properties of porous PMMA based cements. (a) Porosity of porous PMMA based
cements; (b) Pore size distributions.
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 'LVSHUVLRQ RI &D3 SDUWLFOHV
The μ-CT scan allowed the detection of CaP particles dispersed throughout the
porous PMMA matrix based on their difference in radiopacity. After preparation, the
cross-sectional view and 3D-reconstruction showed that both CaP particles were
exposed outside the surface. Big non-setting CaP particles were homogenously
dispersed throughout the porous PMMA matrix, whereas small reactive CaP
particles formed CaP agglomerations within the pores ()LJ ).
SEM analysis further confirmed the porous structure of the PMMA matrix and
distribution of CaP particles ()LJ ). Small CaP particles filled the pores of
srpPMMA as an agglomerated phase, whereas the big CaP particles were partially
embedded in the PMMA matrix as single, dispersed particles for the bppPMMA
samples.
)LJ μ-CT graphs of porous PMMAbased cements for 0 day and 28 days. Scale bar represents 1 mm.
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)LJ  Morphology of porous PMMA-based cements. Porous structure of pPMMA sample at low (a)
and high (d) magnification; distribution of CaP particles within the porous PMMA matrix at low (b, c)
and high (e, f) magnification. sCaP and bCaP refer to small CaP particle and big CaP particles,
respectively.
 0LQHUDOL]LQJ FDSDFLW\ RI FHPHQWV
The PMMA matrix did not reveal any radiopaque features before SBF immersion. After
immersion for 28 days, however, radiopaque spots could be observed in the pPMMA
group, most likely due to mineralization of the PMMA matrix ()LJ ). For CaP loaded
groups it was not possible to discern CaP particles from possible mineralization upon
immersion in SBF ()LJ .
SEM observation further confirmed the mineral formation after immersion. After 28
days, some granular precipitates were observed on the pore surface of PMMA
composition (pPMMA and PMMA area in srpPMMA and bppPMMA samples) (black
arrows). In contrast, abundant flake-like precipitates and few needle-like
precipitates formed onto the surfaces of small, reactive CaP particles and big,
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passive CaP particles, respectively (white arrows in )LJ ).
XRD analysis ()LJ ) revealed the crystal phases present before and after
immersion in SBF. Before immersion only reflection peaks corresponding to the
main CaP phases were identified, i.e., Į-TCP for srpPMMA and ȕ-TCP as well as
HA for bppPMMA. After an immersion period of 28 days, the hydrolysis of Į-TCP
into an apatite-like structure with some ȕ-TCP was detected in the srpPMMA
sample. On the other hand, no changes in crystallographic structure were observed
for bppPMMA. The CaP-free pPMMA control group also revealed the presence of a
precipitated apatitic CaP phase after an immersion period of 28 days, which
correlated with the results from μ-CT and SEM analyses.
)LJ  Morphology of PMMA-based cements after immersion in SBF for 28 days. Black arrows
indicate the precipitates formed on PMMA surface after SBF immersion; white arrows correspond
to precipitates formed on CaP particle surfaces after SBF immersion.
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)LJ  XRD patterns of porous PMMA based cements before and after immersion in SBF for 28
days. (* = apatite; # = ȕ-TCP; + = Į-TCP; · = HA)
 0HFKDQLFDO SURSHUWLHV
The results of the compressive tests are displayed in )LJ  The ıy of samples
ranged between 5.3 to 7.8 MPa, while the E varied from 120 to 190 MPa, but no
statistical significance was found among the various groups as well as various time
points regarding both ıy and E.
)LJ  Mechanical properties of porous PMMA based cements after immersion in SBF at different
time points.
 'LVFXVVLRQ
The aim of the current study was to evaluate the physiochemical properties and LQ
YLWUR mineralization ability of porous PMMA loaded with different CaP particles. The
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results indeed confirmed that the size of CaP particles influenced their distribution
throughout the porous PMMA scaffold and the porosity and pore size distribution of
cements after fabrication. The composition of CaP particles influenced their
mineralizing capacity after soaking in SBF. The incorporation of both CaP particles
did not affect the peak polymerization temperature as well as mechanical properties
of cements.
Several studies showed that the high temperatures observed during the exothermic
polymerization reaction of MMA can induce thermal necrosis of bone tissue, since
temperatures of up to 80°C can be reached [23-25]. However, the peak
polymerization temperature as measured for porous PMMA in the current study was
close to room temperature for all the samples. This low polymerization temperature
can be attributed to the lower volume density of MMA monomers in porous PMMA,
while the aqueous CMC gel can also reduce heating corresponding [7, 14]. Addition
of CaP particles did not compromise this beneficial low polymerization temperature,
even though CaP ceramics exhibit a poor thermal conductivity.
The porous structures of cements were fabricated by a one step process using
CMC hydrogel as pore generator. Due to the phase separation of the hydrophilic
CMC and the hydrophobic MMA, an open porosity with pore interconnectivity was
formed as confirmed by SEM and MIP techniques. Compared with pPMMA cement,
srpPMMA and bppPMMA cements resulted into decreased porosity and pore sizes
due to the incorporation of CaP particles. Moreover, precipitated hydroxyapatite as
present in the small, reactive particles might have contributed to the decreased
porosity according to the “pickering effect”.
SEM and XRD analyses indicated that the CaP-free cement also mineralized upon
soaking in SBF, which was consistent with our previous study [13]. We suggest that
the CMC in samples contained abundant carboxyl functional groups which are
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known to be effective sites for apatite nucleation [26, 27], while supersaturation of
the surrounding SBF can accelerate the nucleation process and growth onto the
surface of porous PMMA [26]. Regarding the mineralization behavior of CaP-loaded
PMMA cements, it was concluded that the introduction of CaP particles successfully
introduced osteoconductive CaP phases into the porous PMMA as confirmed by
intense reflections characteristic of Į-TCP peaks (in srpPMMA) and ȕ-TCP and HA
peaks (in bppPMMA). After immersion in SBF, the interconnected porous structure
of the samples facilitated reactions between the incorporated CaP particles and
SBF. SEM and XRD analysis confirmed that small, reactive CaP particles were
more prone to phase transformation than big, passive biphasic CaP particles upon
soaking in SBF. Specifically, Į-TCP particles as present in the small reactive CaP
powder particles could dissolve in SBF and subsequently transform into apatitic
CaP, which is consistent with our previous studies [28, 29].On the contrary, big
passive biphasic CaP particles were included into porous PMMA cements without
any transformation reaction.
It is known that human cancellous bone presents ıy and E values of 4~12 MPa and
50~800 MPa, respectively [30-32]. Therefore, the ıy and E values of all porous
PMMA samples prepared in this study match the strength and stiffness of
cancellous bone, which is highly beneficial in view of possible stress shielding
effects and corresponding reduction of the fracture risk when compared with
conventional dense PMMA of much higher strength and stiffness[13, 33].
Furthermore, no significant differences were found among the various groups,
which means that the addition of high amounts of CaP powders (even up to the
same amount as the PMMA phase) did not weaken the final bulk mechanical
properties. These mechanical properties were also not affected by the type of CaP
particles or the immersion time in SBF.
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 &RQFOXVLRQV
The incorporation of CaP particles into porous PMMA did not influence the
maximum polymerization temperature, but reduced the porosity and average pore
size of porous PMMA samples. Small setting CaP particles formed CaP
agglomerations within the PMMA pores, whereas the big millimeter-sized CaP
particles were partially embedded in the PMMA matrix and partially exposed to the
pores. Both types of CaP particles enhanced the mineralization capacity of PMMA
cement without compromising their mechanical properties irrespective of the size
and chemistry of the particles. The data presented herein suggest that porous
PMMA/CaP cement hold strong promise for surgical application in bone
reconstruction.
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$EVWUDFW
The aim of this study was to evaluate the effect of carboxymethylcellulose (CMC) as
a pore generator and hydroxyapatite (HA) as an osteoconductive agent on the
physicochemical properties and LQYLWUR mineralization ability of porous
polymethylmethacrylate (PMMA) cement. To this end, various compositions of
PMMA cements, which differed in amount of millimeter-sized hydroxyapatite (HA)
particles and CMC hydrogel, were prepared and immersed into simulated body fluid
(SBF) for 0, 7, 14, 21 and 28 days. It was demonstrated that the incorporation of
CMC hydrogel decreased the maximum temperature of cement to the normal body
temperature and prolonged the handling time during polymerization. Further, the
amount of CMC was responsible for the creation of porosity and interconnectivity,
which in turn determined the final mechanical properties of cements. The loaded HA
particles enhanced the potential bioactivity of cement for bone ingrowth. Albeit
different amount of HA particles influenced their final exposures on the surface of
cured cement, all of the three amounts of HA did not weaken the final mechanical
properties of cements. The data here suggests the HA particle loaded porous
PMMA cement can serve as the promising candidate for bone reconstruction.
.H\ZRUGV
3RURXV SRO\PHWK\OPHWKDFU\ODWH +\GUR[\DSDWLWH &HPHQW
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 ,QWURGXFWLRQ
Bone defects caused by injuries, diseases or surgeries severely influence the
function, aesthetics, and psychosocial well-being of patients [1]. Consequently,
bone reconstruction is essential for patients’ daily lives. Among numerous
alternative materials proposed for bone reconstruction, polymethylmethacrylate
(PMMA) bone cement occupied a unique space for several decades due to its
desirable characteristics, e.g. sufficient strength to provide mechanical support,
moldable to fill complex defects, low price and FDA-approved [2, 3]. However,
PMMA has also been found to possess unfavorable properties. For instance, PMMA
polymerization elevates temperature which results in thermal damage to
surrounding tissues. Moreover, aseptic loosening of the implanted cement has been
observed in a high rate of patients due to the poor bioactivity and inappropriate
mechanical properties of PMMA [4]. As a consequence, the modification of PMMA
has attracted a lot of research interest.
Among numerous approaches to improve PMMA, the inclusion of pore forming phase,
e.g. carboxymethylcellulose (CMC) hydrogel, to generate open porosity was considered
as an effective way. Previous studies have proven that porous PMMA allows bone
ingrowth into the created porosity resulting in the establishment of a mechanical anchor at
the PMMA-bone interface [5]. Further, porous PMMA showed a beneficial effect on
mechanical properties, polymerization temperature, soft-tissue healing and drug-eluting
ability in comparison with solid PMMA [3, 5-10]. Building upon these advantages, the next
step is to modify porous PMMA by adding bioactive mineral phases into the extracellular
matrices (ECMs)-like hydrogel porogen to mimic the composition and structure of bone in
the local sites and meanwhile facilitate the mineralization process to obstruct the
formation of unfavorable fibrous capsule [11, 12].
In recent years, our group performed a series of studies to fabricate porous
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PMMA-calcium phosphate (CaP) cements and investigated their physiochemical
properties and bioactivity both LQYLWUR and LQ-YLYR [13-15]. Unlike gel growth method
for biomineralization LQYLWUR [16-19], we simply load CaP particles with CMC
hydrogel during the preparation of PMMA. The initial LQYLWUR results showed that
CaP particles could be successfully loaded into the porous PMMA structure without
influencing the chemical composition of PMMA [13]. Moreover, CaP particles
enhanced the mineralization capacity of PMMA cement without compromising the
mechanical properties. It was also found that the size of CaP particles influenced
their distribution pattern in porous PMMA and therefore affected the final porous
structure of the cement: small micrometer-sized CaP particles agglomerated within
the PMMA pores, whereas big millimeter-sized CaP particles were partially
embedded in the PMMA matrix and partially exposed to the pores [15]. The LQYLYR
study suggested the latter combination to be ideal for bone formation and ingrowth
due to the exposure of CaP particles, which were in direct contact with bone [14].
Consequently, we focused on further optimization of this material in the current
study.
It is known that the porosity of PMMA correlates with its mechanical characteristics
and final tissue response, which can be controlled by the amount of pore generator,
i.e., CMC hydrogel [3, 20]. Additionally, the amount of incorporated CaP particles is
associated with the potential biological ¿xation of the cement [13]. Consequently,
the compromise between the percentage amount of CMC hydrogel and the CaP
particles in porous PMMA/CaP should be established for future clinical use. In view
of this, we prepared various compositions of PMMA cements, which differed in
amount of millimeter-sized hydroxyapatite (HA) particles and CMC hydrogel.
Subsequently, the initial physicochemical properties, mineralization capacity and
mechanical properties of the various specimens were determined. The mechanical
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characterization was done before and immediately after soaking of the specimens
in simulated body Àuid (SBF).
 0HWKRGV
 0DWHULDOV IRU FHPHQW SUHSDUDWLRQ
PMMA powder (Dentalbiolux International, Belgium) was mixed with 1% Dibenzoyl
peroxide (BPO, Acros Organics,Geel, Belgium), which served as a radical
polymerization initiator. Methylmethacrylate (MMA, Acros Organics, Geel, Belgium)
was mixed with 2% N,N-dimethyl-p-toluidine (DMPT, Sigma–Aldrich Chemical,
Zwijndrecht, the Netherlands), which acted as an accelerator for the polymerization
reaction. Sodium carboxymethylcellulose (Na-CMC, AkzoNobel (Akucell AF 2205,
Arnhem, the Netherlands) was used as a pore forming phase and sintered
hydroxyapatite (HA, Merck, Darmstadt, Germany) with a particle size of 1.0 - 1.5
mm acted as osteoconductive particles.
 3RURXV 300$ DQG FRPSRVLWHV SUHSDUDWLRQ
Porous PMMA samples were prepared using the method as described before
[13-15]. The specimens consisted of a PMMA matrix and a pore generator. The
PMMA matrix was prepared by mixing the solid and liquid components. Firstly, 2.00
g of PMMA powder was pre-mixed with 0.08 g BPO powder to form the solid
component of the PMMA matrix. Then, 1.00 g MMA solution was pre-mixed with
0.02 g of DMPT solution to form the liquid component. Pore generator was prepared
from CMC and water. Two different amounts of pore generator with the same
viscosity were used in this study, i.e. 5%CMC and 7%CMC, respectively (Table 1).
Then, the solid and liquid components of the PMMA matrix were manually stirred
together. Subsequently, CMC hydrogel was added to the PMMA matrix until a
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homogeneous paste was obtained. Depending on the formulation, millimeter-sized
HA particles, which were 0.5, 1 or 1.5 times of the weight of the PMMA matrix, were
added and mixed through the paste. Table 1 shows the respective sample groups.
Once this paste reached a dough-like consistency, it was packed into Teflon moulds.
Moulds with two different dimensions were used. Cylindrical samples with 6 mm
diameter × 12 mm height were used for mechanical measurements based on the
international organization for standardization Standard ISO5833 [2, 21]. Cylindrical
samples with 10 mm diameter × 18-mm-height were used for the other
measurements. After curing overnight, samples were unmolded, MilliQ water
washed, freeze-dried and imaged by a Nikon D90 digital camera.
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 0HDVXUHPHQWV RI PD[LPXP WHPSHUDWXUH DQG KDQGOLQJ WLPH
Once the homogeneous mixture was packed into the moulds, the polymerization
temperature was monitored by a type K thermocouple (Testo 925, Lenzkirch,
Germany). The probe of the thermocouple was located at the center of the sample
surface and the highest temperature (Tmax) during the polymerization reaction was
recorded according to our previous study [15]. Further, the handling time was
recorded, which was defined as the time immediately after mixing till the bone
cements become hard to shape. All the measurements were performed in triplicate
(n = 3) at room temperature, i.e. around 23 ºC.
 0LFURFRPSXWHG WRPRJUDSK\ &7 PHDVXUHPHQW
A high-resolution -CT (SkyScan 1072, Skyscan, Belgium) was used to examine
the porous structure of PMMA matrix and distribution of HA particles. One
representative sample from each group was placed in a custom-made holder to
ensure that the long axis of the samples was oriented perpendicular to the axis of
X-ray beam. A pixel size of 18.88 m, with acquiring conditions of 100 kV, 98A, a 1
mm Al filter and a rotation step of 0.90° per slice were used. NRecon® (SkyScan,
Belgium) software was used to reconstruct the acquired image slices. Around 640
slices per sample were generated. Reconstructed images were then processed with
CTAn® software (SkyScan, Belgium).
 3RURVLW\ FDOFXODWLRQ
7KH SRURVLW\ RI VDPSOHV ZDV PHDVXUHG DQG FDOFXODWHG EDVHG RQ D JUDYLPHWULF
PHWKRG
Porosity = [1 – (MHA / ȡHA + MPMMA / ȡPMMA) / Vsample] × 100%
where MHA and MPMMA are the weights of HA proportion and PMMA proportion in the
sample, respectively; ȡHA (3.16g/cm3) and ȡPMMA (1.18g/cm3) are the densities of HA
– 105 –
5
524973-L-bw-Sa
Processed on: 12-10-2018 PDF page: 106
and PMMA, respectively; Vsample is the volume of sample. Accordingly, (MHA / ȡHA) /
Vsample and (MPMMA / ȡPMMA) /Vsample are the volume percentages of HA and PMMA
portions, respectively. For the groups without HA, MHA is regarded as 0 and MPMMA
could be obtained directly. For the groups loaded with HA, samples were first
immersed in 10% nitric acid for 3 days to dissolve HA. After confirming that all the
HA particles were dissolved by micro-CT ()LJ), MPMMA and MHA were calculated by
measuring the weight of samples. Three samples from each group were used to
calculate the average porosity.
)LJ Preview morphologies of PMMA-5%CMC-0.5HA and PMMA-7%CMC-1.5HA cements from
μ-CT.
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 6%) LPPHUVLRQ
SBF solution was prepared by using the method of Kokubo to test the mineralization
ability of prepared cements [22]. The comparison of ion concentrations between
SBF and human blood plasma was shown in 7DEOH  [23, 24]. The LQYLWUR
immersion test was carried out by soaking each sample at 37 °C in 10 ml SBF,
which was refreshed weekly. After 3, 7, 14, 21 and 28 days, samples were washed
in MilliQ water, air-dried and used for the following studies along with the unsoaked
samples.
Table 2 Ion concentrations, in mM (mmol-1), of SBF and human blood plasma
1D . 0J &D &O +&2 +32 62
6%)        
+XPDQ EORRG SODVPD        
 6FDQQLQJ HOHFWURQ PLFURVFRS\ 6(0 REVHUYDWLRQ
SEM (JEOL 6340; Japan) performed on the cross-section of fractured samples was
used to analyze the porous structure and morphology. Fractured samples were
mounted on aluminum stubs using conductive carbon tape, sputter coated with gold
using a JEOL JFC-1200 sputter coater and then examined using SEM (JEOL 6340;
Japan) at an accelerating voltage of 10 kV and working distance of 15 mm.
 (YDOXDWLRQ RI FXPXODWLYH FDOFLXP XSWDNH
Cumulative calcium uptake of cements after immersion was evaluated by assessing
the remaining calcium concentration in SBF after 3, 7, 14, 21 and 28 days. In brief,
the SBF samples were mixed with 0.5 N acetic acid solution at room temperature
overnight. Then remaining calcium concentration was measured by the
ortho-cresolphthalein complexone (OCPC) method [25, 26]. First, 80 mg OCPC
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(Sigma) was added in 75 ml H2O with 0.5 ml 1 N KOH and 0.5 ml 0.5 M acetic acid
to prepare the OCPC solution. Then, working solution was prepared according to
the following formula: 5 ml OCPC solution was added to 5 ml 14.8 M
ethanolamine/boric acid buffer (pH = 11), 2 ml 8-hydroxyquinoline and 88 ml MilliQ
water. Finally, 300 μl working solution was added to 10 μl SBF sample or standard
CaCl2 solution and calcium concentration was measured at 570 nm with a
spectrofluorometer. Five SBF samples (n=5) from each group were used to obtain
the average values of remaining calcium concentration and the cumulative calcium
uptake of cements.
 0HDVXUHPHQWV RI PHFKDQLFDO SURSHUWLHV
Mechanical compression testing was performed by using a material test machine
(858 MiniBionixII®, MTS, USA). Compressive yield strength ( y) and modulus of
elasticity (() were measured at a crosshead speed of 0.5mm/min (Q = 5). Unlike the
other tests, the mechanical properties were performed before, but also immediately
(without drying) after samples were taken out of the SBF at the end of their
respective immersion periods.
 6WDWLVWLFDO DQDO\VLV
Data was reported as mean ± standard deviation and statistically analyzed using a
one-way ANOVA with a 95% confidence interval (SPSS 16.0). A post-hoc Tukey test
was performed and the results will be considered significantly different when p <
0.05.
– 108 –
5
524973-L-bw-Sa
Processed on: 12-10-2018 PDF page: 109
 5HVXOWV
 7PD[ DQG KDQGOLQJ WLPH
The data for the Tmax and handling time are listed in 7DEOH . During the
polymerization, there was no obvious exothermic reaction as indicated by the 7PD[,
which varied from 28.23 - 36.90 °C. Only a significant difference existed between
PMMA-5%CMC and PMMA-7%CMC-1.5HA (P = 0.019). The handling time varied
from 7.22 to 7.61 min and there was no significant difference among the groups (P >
0.05).
Table 3 Maximum temperature at the surface and handling time in different
groups
0D[LPXP WHPSHUDWXUH & +DQGOLQJ WLPH PLQ
PMMA-5%CMC 36.90 ± 2.78 7.26 ± 0.46
PMMA-5%CMC-0.5HA 33.20 ± 1.11 7.61 ± 0.10
PMMA-5%CMC-1HA 31.47 ± 2.72 7.22 ± 0.25
PMMA-5%CMC-1.5HA 30.50 ± 1.30 7.52 ± 0.30
PMMA-7%CMC 32.37 ± 2.11 7.25 ± 0.38
PMMA-7%CMC-0.5HA 30.97 ± 0.15 7.54 ± 0.06
PMMA-7%CMC-1HA 30.20 ± 0.75 7.30 ± 0.04
PMMA-7%CMC-1.5HA 28.23 ± 0.40 7.45 ± 0.48
 6XUIDFH PRUSKRORJ\
The surface morphologies of cement samples are shown in )LJ  Larger pores on
the sample surface could be found in the groups with 7% CMC than those with 5%
CMC. Furthermore, the incorporated HA particles (depicted in blue color) were
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homogeneously dispersed on the surface and exposed within the pores. As the
amount of HA increased, more HA was found on the surface.
)LJ  Surface morphologies of porous PMMA based cements.
 &7 UHVXOW
Due to the big difference in radiopacity between the HA particles and PMMA matrix,
it was impossible to reconstruct both PMMA matrix and HA accurately in the same
image for the HA-loaded samples. Therefore, we used different thresholds to
determine the porous structure of the PMMA matrix and the distribution of the
incorporated HA particles ()LJ ). For all compositions of the HA loaded samples,
HA particles were dispersed homogenously and separately throughout the porous
PMMA matrix.
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)LJ  3D-reconstructions of porous PMMA based cements from μ-CT.
 3RURVLW\ UHVXOW
The volume fractions of HA and PMMA and the porosity of samples are listed in 7DEOH .
For 5%CMC cement groups, PMMA-5%CMC-1HA and PMMA-5%CMC-1.5HA showed
significantly lower porosity than PMMA-5%CMC and PMMA-5%CMC-0.5HA (P < 0.05).
No significant difference in porosity was found between PMMA-5%CMC and
PMMA-5%CMC-0.5HA (P = 0.999) or between PMMA-5%CMC-1HA and
PMMA-5%CMC-1.5HA (P = 0.963). For 7%CMC cement groups, the porosity of
PMMA-7%CMC-1.5HA was significantly lower than those of the other three groups (P <
0.05). No significant difference in porosity was found among PMMA-7%CMC,
PMMA-7%CMC-0.5HA and PMMA-7%CMC-1HA (P > 0.05). Further, comparison of
samples with a similar amount of HA, showed that 7%CMC cement samples always
revealed higher porosity than their 5%CMC counterparts.
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 6(0 REVHUYDWLRQ
Cements were immersed in SBF solution up to 28 days for simulation of LQYLYR
implantation. SEM photographs showed no distinguishable differences between
samples loaded with different amount of CMC or HA. Fig.4-5 demonstrated typical
internal structures of PMMA cements with or without HA using the micrographs from
PMMA-7%CMC-1.5HA and PMMA-5%CMC, respectively. At low magnification
(×100), the porous structure of PMMA and the remained CMC film (as indicated by
white dash arrows) after drying were confirmed in all cements. When HA was
incorporated, these particles were partially embedded in PMMA and exposed within
the pores. After immersion in SBF, CaP-like deposition was observed on the surface
of the HA particles (as indicated by a white solid arrow). At high magnification
(×1000), interaction between cement and SBF became more evident. CaP-like
depositions occasionally formed in the internal structure of HA-free PMMA cement
(as indicated by black arrows). In contrast, denser and thicker CaP-like depositions
were found in the internal structure of HA-loaded cement with the increase of
incubation time.
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)LJ  SEM images of porous PMMA based cements after immersion in SBF at different time point,
i.e. 0, 14, 28 days (×100). Scale bar represents 100 μm. White solid arrow indicates the observed
CaP-like depositions on the surface of HA particle. White dash arrows indicate the CMC films after
drying.
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)LJ  SEM images of porous PMMA based cements after immersion in SBF at different time point,
i.e. 0, 14, 28 days (×1000). Scale bar represents 10 μm. Black solid arrows indicate the observed
CaP-like depositions in the internal structure of cements. White dash arrows indicated the CMC
films after drying.
 &XPXODWLYH FDOFLXP XSWDNH RI FHPHQWV
The cumulative calcium uptake of cements during SBF immersion is shown in )LJ .
During the first 7 days, all groups revealed obvious uptake of cumulative calcium
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ions and the HA-loaded groups presented more uptake than HA-free groups. In the
following 21 days, cumulative calcium uptake of all cements continued to increase
in the weekly refreshment SBF. In general, all the groups showed a significant
increase in cumulative calcium uptake after 28 days compared with the initial values
(P < 0.05). The HA-loaded groups induced a significantly larger increase in
cumulative calcium uptake than HA-free PMMA groups, but no statistical significant
differences existed between all the HA-loaded groups or between the two HA-free
groups (P > 0.05, P > 0.05, respectively).
)LJ  Cumulative calcium uptake of cements after soaking in SBF at different time points.
 5HVXOWV RI PHFKDQLFDO SURSHUWLHV
The mechanical results are displayed in )LJ . The ıy of groups incorporated with
5% CMC ranged from 7.5 to 9 MPa, while the E varied between 190 to 240 MPa.
For groups incorporated with 7% CMC, the ıy ranged from 2.5 to 4.5 MPa and the E
varied from 80 to 115 MPa. No statistical difference was found between groups with
the same CMC hydrogel concentration for these two mechanical properties (P >
0.05, P > 0.05, respectively), but significant differences were found between
different CMC hydrogel concentrations for both ıy and E (P < 0.05, P < 0.05,
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respectively). During incubation time, the mechanical properties of the samples did
not change significantly.
)LJ Mechanical properties of porous PMMA based cements after immersion in SBF at different
time points.
 'LVFXVVLRQ
The aim of this study was to evaluate the effect of CMC and HA on the
physicochemical properties and LQYLWUR mineralization ability of porous PMMA
cements over time. The obtained information will be used for further optimization of
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the osteocompatibility of the cements. The results indeed confirmed that the amount
of CMC hydrogel determines the overall porosity of cements, which further affects
the final mechanical properties of the cement. The loaded HA particles enhanced
the mineralization ability of cement. Although different amounts of HA particles
influenced their distribution throughout the porous PMMA scaffold and final
exposure on the surface of cured cement, the incorporation of HA did not weaken
the final mechanical properties of the cement.
High polymerization temperature is one of the major disadvantages of conventional
PMMA and this exothermic reaction during setting could even reach up to 80°C
[27-29]. However, the Tmax measured for all the porous PMMA based cements was
lower than human body temperature, i.e, around 37 ºC. Therefore, all the samples
in our study mitigated the risk for thermal necrosis of the surrounding tissues. This
result is consistent with previous studies, where porous PMMA was fabricated by
using the CMC hydrogel as pore generator and major contributor for the
temperature decrease [9, 15, 20]. Further, it has to be noticed that a significant
difference in Tmax existed between PMMA-5%CMC and PMMA-7%CMC-1.5HA.
This difference indicates that the incorporation of HA contributes also to the
decrease of heat. Since the amount of released heat is correlated to the
polymerization speed of PMMA, a decreased Tmax is associated with a prolonged
handling time. In this study, the handling time was found to be around 7 min for all
cements. This time provides sufficient time for surgeons to manipulate the cement
without using additional techniques, such as pre-cooling the cement or decreasing
the operation room temperature, to extend the polymerization process.
Surface composition and cement structure influence the bone-cement interface,
which is critical for final clinical application. We observed that an increasing amount
of incorporated HA particles into the cement resulted also in more surface exposed
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particles. As the HA particles are supposed to be osteoconductive and form a direct
chemical bond with bone [30], this seems to be a feasible approach for
PMMA-cement optimization.
μ-CT revealed the interconnected porosity of PMMA and homogenously distributed
HA particles within PMMA matrix. SEM further confirmed the presence of porosity
and HA particles. Since Kokubo and Takadama clearly proved that the
bone-bonding ability of a material is often evaluated by examining the ability of
apatite to form on its surface in a SBF with ion concentrations nearly equal to those
of human blood plasma [23]. Prepared cements were immersed into SBF to
evaluate their potential mineralization abilities. SEM clearly revealed that HA-free
cements showed very limited interactions with SBF, which is consistent with our
previous studies [13, 15]. That was because when samples were immersed into
SBF, the carboxyl functional groups in CMC films are effective sites for apatite
nucleation [31, 32]. In contrast, the HA particles in HA-loaded cements provided
more favorable surfaces for apatite nucleation, which resulted in the precipitation of
abundant CaP-like deposits on the surfaces of the HA particles. Evidently, the
HA-loaded cements improved the mineralization ability compared with HA-free
cements.
Cumulative calcium uptake analysis confirmed the mineralization ability of the
cements quantitatively. A clear increase of cumulative calcium uptake could be
observed for all cements after 28 days in weekly refreshed SBF, indicating
continuous calcium phosphate precipitations from SBF into cements. This can be
explained by the fact that the carboxyl functional groups of CMC films and HA
particle induced apatite nucleation and formation of precipitations. Then the existed
precipitates provided more nucleation sites for further precipitate formation, which
resulted denser and thicker depositions with the increase of incubation time as
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observed by SEM. When further compare HA-loaded and HA-free cements, it was
found that all HA-loaded cements induced greater cumulative calcium uptake from
SBF than HA-free cements. However, no significant effect of the amount of
incorporated HA particles on the cumulative calcium uptake increase was found.
This indicates that under the current experimental conditions, a higher amount of
loaded HA does not result in better mineralization ability. An explanation for this
observation can be the composition of used CaP particle, which were composed of
sintered HA. This material is known to possess a limited ability to react with SBF [33,
34].
The ıy and E data indicate that the mechanical properties of the cements are mainly
determined by the amount of CMC hydrogel. The addition of HA particles did not
reduce the final bulk mechanical properties of cements. The porous structure of our
PMMA based cements were produced by mixing hydrophilic CMC hydrogel with the
hydrophobic PMMA cement. To maintain the same CMC/water ratio, 7% CMC was
mixed with more water than 5% CMC and a higher porosity was created in
PMMA-7%CMC cements. As a consequence, PMMA-7%CMC cements showed a
lower ıy and E compared to PMMA-5%CMC cements, which corroborates with the
typical porosity-mechanical property relationship in scaffold materials [2, 9, 35].
When additional HA particles are incorporated, the resulting porous PMMA/HA
cements present a higher degree of complexity, since the mechanical behavior of
the cements is now affected by the interactions between the porous scaffold and the
loaded HA particles. It has to be noticed that with an increasing amount of HA
particles, the amount of PMMA matrix per volume was decreased accordingly
(7DEOH ). Therefore, the compromise between the amounts of HA and PMMA
retained the balance for the final mechanical properties of cements. The ıy and E
value of human cancellous bone is 4~12 MPa and 50~800 MPa, respectively [15,
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36, 37]. All our experimental cements show mechanical values close to those of
cancellous bone, which suggests that these materials will allow a better stress
distribution and reduce the risk of fractures compared with the conventional solid
PMMA [38, 39].
 &RQFOXVLRQ
In the current study, we characterized the LQYLWUR physicochemical properties and
mineralization ability of porous PMMA based cements. The incorporation of CMC
hydrogel decreased the maximum temperature of cement to the normal body
temperature and prolonged the handling time during polymerization. Further, the
amount of CMC hydrogel affected the overall porosity of the cement, which in turn
determined the final mechanical properties. The loaded HA particles enhanced the
mineralization ability of cement. Further, different amounts of incorporated HA
particles influence the final exposure of HA on the surface of cured cement. On the
other hand the addition of HA up to 1.5 wt% did not reduce the mechanical
properties of the cements. Future studies have to prove the clinical advantage of
these porous PMMA/HA based cements for bone reconstruction.
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$EVWUDFW
The aim of the current study was to evaluate bone formation and tissue response to
porous polymethylmethacrylate (PMMA) cement with or without hydroxyapatite (HA)
in a rabbit mandibular model. Therefore, fourteen New Zealand white rabbits were
randomly divided into two groups of seven according to the designed study end
points of 4 and 12 weeks. For each rabbit, two decorticated defects (6 mm in height
and 10 mm in width for each) were prepared at both sides of the mandible.
Subsequently, the defects were filled with respectively porous PMMA and porous
PMMA-HA cement. After reaching the designated implantation period, the rabbits
were euthanized and the mandibles were retrieved for histological analysis. Results
showed that both porous PMMA and porous PMMA-HA supported bone repair.
Neither of the bone cements caused significant inflammation to nerve or other
surrounding tissues. After implantation of 12 weeks, majority of the porosity was
filled with newly formed bone for both cements, which supports the concept that a
porous structure within PMMA can enhance bone ingrowth. Histomorphometrical
evaluation, using histological grading scales, demonstrated that, at both
implantation times, the presence of HA in the PMMA enhanced bone formation.
Bone was always in direct contact with the HA particles, while intervening fibrous
tissue was present at the PMMA-bone interface. On the basis of results, it was
concluded that injectable porous PMMA-HA cement might be a good candidate for
craniofacial bone repair, which should be further evaluated in a more clinically
relevant large animal model.
.H\ ZRUGV
Porous PMMA; Hydroxyapatite; Bone
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 ,QWURGXFWLRQ
Bone is a uniquely strong and rigid tissue, which forms the skeleton and supports
the human body [1]. Bone can be severely damaged by traumatic injuries, fractures
or congenital disorders, leading to one of the most critical public health issues in the
world [2]. Although bone has considerable ability to self-regenerate, bone grafts are
often needed to repair bone defects. Among these bone graft procedures,
craniofacial repair or reconstruction is particularly challenging as the bone in this
area shows a morphologically complex structure and plays a pivotal role in
maintaining the psychosocial well-being of patients [3-5]. Nowadays, injectable
bone substitutes (IBSs) become increasingly attractive in craniofacial bone surgery
as they offer apparent advantages, like the use of less invasive surgical procedures
and effective fit of the material to the irregular shaped bone defect [6-8]. The
application of IBSs may alleviate patients’ discomfort and reduce the recovery time
as well as treatment cost [9].
,QVLWX curing poly(methyl methacrylate) (PMMA) is already widely used as “bone
cement” to fix orthopaedic implants [10-13]. However, due to its bio-inertness and
inappropriate stiffness, a high proportion of aseptic loosening at the PMMA
cement-bone interface is observed [13]. To circumvent these problems, porous
PMMA was developed by incorporating a biodegradable, hydrophilic hydrogel, like
carboxy methyl cellulose (CMC) into the non-degradable, hydrophobic PMMA
[14-16]. After degradation of the hydrogel, the resulting porosity had to facilitate
bone tissue ingrowth and to improve cement-bone anchorage. In addition to
orthopaedics, porous PMMA was also used for correction of craniofacial defects
and a long-term study confirmed indeed the occurrence of bone ingrowth into the
porous PMMA [14]. Although successful, the study showed that the bone did not
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penetrate deep into the porosity. Additional animal studies revealed that the porous
PMMA surface was covered by a fibrous tissue capsule, which had an unfavorable
effect on bone ingrowth [13, 17-19].
Calcium phosphate (CaP) ceramics, like HA, are known to be bioactive and
osteoconductivite [20]. They are able to bond with bone [21]. Therefore, adding a
bioactive component, like calcium phosphate particles, into porous PMMA matrix
seems an effective strategy to optimize the bone performance of the porous PMMA
cement. It can be hypothesized that such a porous PMMA composite favors the
bone response and results in a direct bone contact with the CaP particles at the
composite-bone interface.
To test this hypothesis, a series of LQ YLWUR and LQ YLYR studies with porous
PMMA/CaP composites have been performed in recent years. Initial studies
revealed that CaP particles could be successfully loaded into porous PMMA without
compromising its mechanical property [21]. The synthesized porous PMMA/CaP
composites were biocompatible and supported bone ingrowth and material fixation
[17]. However, the LQ YLYR study also revealed that the porous PMMA/CaP
composites did not increase the amount of bone formation and ingrowth in
comparison with porous PMMA [17]. The micron-sized particles, which were
embedded in CMC gel were found to loosen from the pores and trigger a host
inflammatory response that in turn influenced the chemical bonding to bone LQ YLYR
Consequently, to further optimize the performance of the composite, ranges of
porous PMMA were developed by incorporating different amounts of CaP particles
with diverse sizes and tested LQ YLWUR [22, 23] Large millimeter-sized particles were
found to show superior properties over small micron-sized ones, since the former
could be partially embedded in the PMMA matrix and partially exposed to the pores
for potential bone contact [22]. More interestingly, the increased amount of particles
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enhanced the biomineralization ability of the composite without weakening its
mechanical property [23].
Toward further development as IBS for craniofacial bone tissue repair, the
performance of the LQ YLWUR optimized porous PMMA based composites has to be
verified LQ YLYR. Therefore, the current study was designed to evaluate and compare
the performance of porous PMMA cement and porous PMMA cement loaded with a
high amount of millimeter-sized hydroxyapatite (HA) particles (PMMA-HA) in a
rabbit mandibular defect model. Local tissue response, recovery of the bone defect
and bone ingrowth within the porosity of the PMMA implants were histologically
evaluated after 4 and 12 weeks of implantation.
 0DWHULDOV DQG PHWKRGV
 ([SHULPHQWDO DQLPDOV
This study was approved by the Institutional Animal Care and Use Committee of
Innoheart (2015/022), Singapore. Fourteen (12-month-old male) New Zealand
white rabbits (Oryctolagus cuniculus), each weighing 3-4 kg, were used. Seven
rabbits were designated to each of the implantation times (4 and 12 weeks). The
surgical defect was created bilaterally in the mandible of each rabbit and treated
with the two types of cement (Table 1).
Table 1. Bone cements allocations in the mandibular defects and the designed
sacrificed time points. Cement A = porous PMMA, cement B = porous
PMMA-HA
Animal number Rabbit left mandible Rabbit right mandible Sacrificed time points
1 Cement A Cement B
4 weeks
2 Cement B Cement A
3 Cement B Cement A
6
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4 Cement A Cement B
5 Cement A Cement B
6 Cement B Cement A
7 Cement B Cement A
8 Cement A Cement B
12 weeks
9 Cement A Cement B
10 Cement B Cement A
11 Cement B Cement A
12 Cement A Cement B
13 Cement A Cement B
14 Cement B Cement A
0DWHULDOV IRU FHPHQW SUHSDUDWLRQ
PMMA powder (Dentalbiolux International, Belgium) was mixed with 1% dibenzoyl
peroxide (BPO, Acros Organics, Geel, Belgium), a radical polymerization initiator.
Methyl methacrylate (MMA, Acros Organics, Geel, Belgium) was mixed with 2% N,
N-dimethyl-p-toluidine (DMPT, Sigma–Aldrich Chemical, Zwijndrecht, the
Netherlands), which acted as an accelerator in the polymerization reaction. Sodium
carboxymethylcellulose (Na-CMC, AkzoNobel (Akucell AF 2205, Arnhem, the
Netherlands) was used as a porogen, and sintered hydroxyapatite particles (HA,
Merck, Darmstadt, Germany) with a particle size of 0.5 - 1.0 mm as bioactive
component. Before use, all materials were sterilized by gamma-irradiation at 25 kGy
(Gammastar, Wageningen, The Netherlands).
6XUJLFDO SURFHGXUH DQG GHIHFW SUHSDUDWLRQ
The animals were sedated with ketamine 50 mg/kg (intramuscular, i.m.) and
xylazine 10 mg/kg (intraperitoneal, i.p.) before surgery. Then, antibiotics
(Ampicillin/Cloxacillin 6-8 mg/kg) were injected subcutaneously. General anesthesia
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was maintained by a mixture of nitrous oxide, isoflurane, and oxygen administration
through endotracheal intubation. Under general anesthesia, rabbits were
immobilized on their back. The fur at the submandibular area was shaved and the
skin was disinfected with Povidone-iodine and 70% alcohol. Local anesthesia with
2% xylocaine was injected into the surgical area. Through extra oral approach, a 4
cm incision was made at the inferior border on each side of the mandible. The
tissue was raised to expose the buccal cortices of the mandible including the mental
nerve and foramen. Subsequently, a rectangular mono-cortical bony defect (6 mm
in height and 10 mm in width) at the buccal side of the mandible was created (Fig.
1a). The distal margin of the defect was at 4 mm distance from the anterior border of
the masseteric muscle attachment. The defect depth was about half the thickness
of inferior border of the mandible (Fig. 1b). All defects were made at the inferior
mandibular border region between the second premolar and first molar (Fig. 2a, b).
Hemostasis of inferior alveolar neurovascular bundle was achieved with diathermy
and pressure pack.
),*. Diagram of the designed decorticated defect in the rabbit mandible. a. green rectangle
represents the defect, 6 mm in height and 10 mm in width, which is located buccal to the apices of
the mandibular premolars and molars. b. cross-sectional image of defect depth and inferior
alveolar nerve position.
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),* The defect preparation and cement implantation. a. designed defect border; b. prepared
bone defect; c. porous PMMA cement implantation; and d. porous PMMA-HA cement implantation.
 &HPHQW SUHSDUDWLRQ DQG LPSODQWDWLRQ
Porous PMMA and PMMA-HA cement were prepared according to the previous LQ
YLWUR study [23]. Porous PMMA cement contained two components: PMMA matrix
and porogen (Table 2). 2.00 g of PMMA powder was pre-mixed with 0.08 g BPO
powder as the solid part of the PMMA matrix and 1.00 g MMA solution was
pre-mixed with 0.02 g of DMPT solution as the liquid part of the PMMA matrix. For
the porogen phase, 0.21 g of Na-CMC powder was mixed with 3.99 g of deionized
water to prepare the Na-CMC gel. Then, the solid and liquid parts of PMMA matrix
were manually mixed. Subsequently, Na-CMC gel was added and stirred until a
homogeneous paste was obtained. Once the whole paste reached a dough-like
consistency, it was filled into the mandibular defect with a spatula (Fig. 2c). For
porous PMMA-HA cement (Table 2), 4.5 g HA particles were additionally added to
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the paste, mixed, and then ¿lled in the bone defect (Fig. 2d). Table 1 shows the
randomization scheme as used for the two cement groups. After polymerization of
the cement, the periosteum, and cervical fascia were closed with 5-0 Vicryl® suture
and the skin with 4-0 Vicryl® sutures.
Table 2 Weight of compositions in cements
Cement PMMA matrix(g) Porogen (g) HA (%)PMMA MMA BPO DMPT CMC Water
Porous PMMA 2.00 1.00 0.08 0.02 0.21 3.99 0.00
Porous PMMA-HA 2.00 1.00 0.08 0.02 0.21 3.99 4.50
 3RVWVXUJHU\ FDUH DQG VSHFLPHQ UHWULHYDO
The general condition of the animals was assessed and the animals were returned
to their cage when they were not in distress. Animals were housed in conventional
rabbit cages, which allowed for unrestricted weight-bearing activity and were
observed for signs of pain, infection, and abnormality. Animals received antibiotics
(Baytril, 5mg/kg, once daily, i.m.) for 6 days postoperatively, and analgesics
(Tramadol, 1-3/kg, once or twice daily, i.m.) for 2-3 days post-operatively.
Lactobacillus (1 capsule, once daily, p.o.) was administered for 6 days
post-operatively. At the end of the designed implantation period, the rabbits were
euthanized with intravenous pentobarbital sodium (300 mg/ml) at 100 mg/kg. When
required, an additional dose was given. Subsequently, the mandible was sectioned
vertically at the parasymphyseal region; anterior to the mental foramen and
horizontally at the mid-ramus region. The sectioned mandibles were then fixed in
formaldehyde 10 % for 1 week. Thereafter, the excess muscle and soft tissues were
removed leaving the filled defects with 1 cm of bone margin. The specimens were
subsequently placed in 70% ethanol until further analysis.
 +LVWRORJLFDO SURFHGXUHV
Specimens were dehydrated in a graded series of ethanol (from 70 to 100 vol%)
and embedded in methylmethacrylate (MMA, 99%, stabilized, ACROS Organics™).
After polymerization for 1 week, at least three 10-m thick sections were obtained
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from the defect area of each specimen in a bucco-lingual direction parallel to the
tooth roots using a sawing Microtome technique (Leica SP1600, Leica microsystem,
Welzlar, Germany). The obtained sections were stained with methylene blue and
basic fuchsin. High-quality digital images of all obtained sections were made using
a light microscope equipped with a digital camera (Axio Imager Z1, Carl Zeiss AG
Light Microscope, Göttingen, Germany) to assess the bone defect and the
implanted cement. For better comparative analyses between the two cements, each
section was further divided into three regions of interest: (1) the border of the defect,
(2) the interstitial region within the cement porosity, and (3) the tooth roots and
nerve tissue in close vicinity of the cement and defect area. The histological
evaluation consisted of a descriptive and histomorphometric analysis by two
observers (YS and JAJ), using a modified scoring system(Table 3) [17, 24, 25], to
quantify the tissue response. The viewers reached a consensus on the score of
each section and then assigned a final score in case of differences in the grading
process.
Table 3 Histological grading scales for bone-cements
Description* Tissue response Score
Bridge of defect border No 0
Yes 1
Defect bridging No 0
Yes 1
Quantity of bone ingrowth 0 % 0
1-24 % 1
25-49 % 2
50-74 % 3
75-100 % 4
Interface quality Inflammatory reaction 0
Fibrous tissue capsule 1
Thin localized fibrous tissue not arranged as a capsule 2
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Description* Tissue response Score
Partial bone–cement contact with remodeling lacunae
and minimal intervening soft tissue
3
Direct bone–cement contact without intervening soft
tissue
4
Interstitial quality
Masses of inflammatory cells with little signs of
connective tissue organization
0
Granulomatous reactive tissue containing fibroblasts and
inflammatory cells
1
Fibrous connective tissue, showing fibroblasts, collagen,
adipose tissue
2
Immature bone with osteoid and remodeling lacunae 3
Mature bone without inflammation 4
Interior alveolar nerve Damaged and with inflammation 0
Intact and healthy 1
* Bridge of defect border is scored by evaluating if the new bone forms at the border of the created defect.
Defect bridging is scored by evaluating if the new bone grows across the defect area to form the bone
bridge. Quality of bone ingrowth is scored by evaluating the percentage of bone ingrowth into the
porosity of cement. Interface quality is scored by evaluating the tissue property at the interface of cement
component. Interstitial quality is scored by evaluating the tissue property within the porosity of the
cement. Interior alveolar nerve is scored by evaluating the intact and healthy condition of nerve.
 6WDWLVWLFDO DQDO\VLV
Statistical analyses of the histomorphometric grading results were performed using
GraphPad Prism. Data were reported as mean ± standard deviation and statistically
analyzed using a one-way analysis of variance (ANOVA) and a SRVW KRF Turkey test
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with a 95% confidence interval. The results were considered significantly different
when 3 < 0.05.
 5HVXOWV
 &OLQLFDO H[DPLQDWLRQ
All rabbits underwent the surgical procedure without any problems and recovered
well. No rabbit suffered from any significant complications, resulting in 14 rabbits in
total, with 7 rabbits for each time point. During the specimen transportation, one
4-week porous PMMA-HA specimen was lost. Additionally, one 4-week porous
PMMA cement specimen appeared to be unsuitable for histological analysis due to
the difficulty in determining the defect area under the microscopy. Therefore, twelve
4-week and fourteen 12-week specimens were included for the final descriptive and
histomorphometric analysis.
 'HVFULSWLYH DQDO\VLV RI KLVWRORJLFDO UHVXOWV
Bone defect, PMMA cement and HA particles could be recognized in all specimens
(),* ). PMMA appeared as empty voids, and HA particles as solid black circles.
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),*. Overview of histological sections. Black asterisks indicate PMMA component appearing as
empty voids, white asterisks indicate HA particles, black arrows show the inflammatory response at
week 4. The scale bar stands for 1,000 ȝm.
At 4 weeks of implantation, healing of the bone defects was initiated. The borders of
the bone defect could be easily identified by discriminating the original and newly
formed bone (),* ). The original, mature bone showed lighter in staining with
many osteocytes in their lacunae, whereas the newly formed bone stained darker
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and had a less organized, trabecular structure. Bone marrow-like tissue was
present in the voids between the bone trabeculae. At 12 weeks of implantation, the
color and structural discrepancies between the original bone and newly-formed
bone were not obvious. The newly formed bone had remodeled in a compact,
lamellar structure. Nevertheless, at higher magnification, the original defect border
could still be discerned (),* ).
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),* Histological section of the different cements after 4 and 12-weeks of implantation.
Magnified images in the black squared area were displayed below the concurrent images in low
magnification. Black arrows indicate the defect borders, with the right side of the border being the
newly formed bone. At 4 weeks, the original bone and newly formed bone can be differentiated by
the shade of the staining, with lighter staining of mature bone than newly formed bone. At 12 weeks,
the shade and structural discrepancies between the original bone and newly-formed bone are less
obvious and the border can only be discriminated at a higher magnification.
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Further light microscopical analysis of sections revealed that in the 4 weeks porous
PMMA specimens newly formed bone had bridged the porosity of the cement and
closed the defect. However, ingrowth of bone into porosity was not homogeneous
and was limited to the inner side of the cement without bone growth into buccal
direction (),* ). Evidently, the original contour of the mandible was not recovered
yet. In the 4-week porous PMMA-HA specimens similar bone ingrowth was
observed compared with the porous PMMA specimens, but bone did penetrate till
the outer buccal surface of the porous PMMA-HA. At 12 weeks of implantation, the
bone defect was completely bridged for both porous PMMA and porous PMMA-HA
specimens (),* ). Bone ingrowth into porosity had also proceeded in a buccal
direction, but in the porous PMMA-HA specimens bone was more enhanced
compared with PMMA specimens.
The PMMA cement could be detected in the histological sections as an empty
space without the presence of cellular components (),* ). The interstitial regions
of the porous PMMA cement were predominantly occupied by fibrous connective
tissue and newly formed bone was sporadically seen within the pores after 4 weeks.
The PMMA surface was always covered with a fibrous tissue capsule of a few cell
layers thick (Fig. 5). Occasionally, the capsule was associated with an inflammatory
response, as characterized by the presence of inflammatory cells. The capsule was
present at 4 as well as 12 weeks and did not change in appearance. After 12 weeks
of implantation, the interstitial regions of the porous PMMA cement were mostly
filled with bone. In the PMMA-HA specimens, already at 4 weeks a direct contact
between the HA particles and ingrowing bone was observed (),* ). Also, at sites
where HA particles stuck out of the cement, such a direct bone-HA contact was
observed, while the PMMA component was covered with a fibrous tissue capsule.
In the PMMA-HA specimens, the interstitial regions were always filled with bone
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tissue at both 4 and 12 weeks of implantation. Although, at 12 weeks of implantation,
an increase was observed in thickness of the bone layer that covered the HA
particles. No degradation of the HA particles was observed during implantation time
and no osteoclasts cells were seen in close vicinity of the HA particles. Also, the
histological sections show that the amount of HA particles was limited compared
with the amount of PMMA matrix (),*.  .
Although the mandibular nerve was freed from the mandibular canal during surgery,
they were not always visible in the histological sections. When present, the nerves
were found intact and were not surrounded by an inflammatory response (),* ).
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),*. Histological observations for the cement interface after 4 and 12-weeks of implantation.
Magnified images in the black squared area were displayed below the concurrent images in low
magnification. Black asterisks indicate the PMMA component appearing as empty voids, white
asterisks indicate HA particles, black arrow show the inflammatory response at week 4.
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),*. High and low magnification images of the inferior alveolar nerve after 4 and 12-week of
implantation. High magnification images were taken from a location as indicated by a rectangle.
The nerves were found intact and were not surrounded by an inflammatory response.
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 +LVWRPRUSKRPHWULFDO DQDO\VLV
Based on the tissue grading score in Table 3, each specimen was scored and data
were statistically analyzed.
All specimens showed bridging of the defect border; the addition of HA nor the
implantation period affected the bridging of the defect border (P > 0.05) (),* ).
Five out of six specimens for porous PMMA cement and two out of six specimens
for porous PMMA-HA cement showed defect bridging at the 4-weeks implantation
time. This difference was not statistically significant (P > 0.05). Six out of seven
specimens for porous PMMA cement and all seven specimens for porous
PMMA-HA cement showed defect bridging at 12–weeks of implantation (P > 0.05).
Comparison between the implantation times showed that defect bridging for the
porous PMMA-HA cement after 12 weeks of implantation had significantly improved
(P < 0.05) (),* ).
For the quantity of bone ingrowth, no significant difference existed between two
types of cement at the same implantation time (P > 0.05). Bone ingrowth into
porous PMMA did not significantly improve from 4 to 12 weeks (P > 0.05), while
significantly more bone ingrowth had occurred into porous PMMA-HA cement after
12-weeks implantation (P < 0.05) (),* ).
The interface quality for the PMMA component was not significantly different
between porous PMMA and porous PMMA-HA specimens at both 4 and 12 weeks
of implantation (P > 0.05). The interface quality for the HA particles was significantly
better than the interface quality of the PMMA component in the porous PMMA-HA
cements at the two implantation times (P < 0.05) and the interface quality with the
PMMA component as well as HA particles did not change during implantation time
(P > 0.05) (),* ).
As for the interstitial quality, no significant difference of tissue grading score was
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found between porous PMMA and porous PMMA-HA cements at both implantation
time (P > 0.05). But both cements reached higher interstitial quality at week 12 than
week 4 (P < 0.05) (),* ).
Analysis of the inferior alveolar nerve data revealed that no difference existed
between the two cements for the same implantation period and between the
different implantation periods (P > 0.05) (),* ). Almost in all specimens an intact
nerve was present.
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),*. Histomorphometrical analyses for bridging of defect border, defect bridging, quantity of bone
ingrowth, interface quality, interstitial quality, and inferior alveolar nerve. Labelling at x-axis is as
follows: 4 and 12 = implantation time of 4 and 12 weeks, respectively, PMMA = porous PMMA
matrix, HA = HA granules as incorporated into cement, pmma = specific tissue response to pmma
component of the two cement types, and ha = specific tissue response to HA component of the
PMMA-HA cement Asterisk means significant difference between referred groups.
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 'LVFXVVLRQ
The LQ YLYR evaluation is an essential step in the characterization of biomaterials for
their clinical use [24]. The current LQ YLYR study aimed to evaluate the bone behavior
of porous PMMA and porous PMMA-HA cement as a follow-up of our previous
studies [17, 21-23]. Data presented indicate that both porous PMMA and porous
PMMA-HA cement are well-tolerated by the surrounding tissue and support bone
repair. Moreover, incorporation of millimeter-sized sintered HA particles significantly
improves the osteoconductive behavior of the porous PMMA cement.
In this study, a bone defect was created in the rabbit mandible, which was filled with
porous PMMA or porous PMMA-HA cement. A period of 12 weeks was chosen for
implantation as the healing of a bone defect in New Zealand White rabbits takes
around 6-7 weeks [26] and bone remodeling reaches a stable status and maturity at
about 12 weeks postoperatively[27-29].
Cement porosity is known to be crucial for bone and tissue ingrowth LQ YLYR [14, 19].
According to our previous LQ YLWUR study [23], both cements used in this study had
approximately 50% porosity. The data prove that such a porosity is able to
encourage bone ingrowth and to form a mechanical interlock at the implant site,
which corroborates with previous studies [14, 17].
The histological analysis comparing the tissue response between porous PMMA
and porous PMMA-HA cement demonstrated the osteoconductive potential of the
HA particles. Evidently, the HA particles supported the ingrowth of bone into the
cement porosity and direct bone contact with the HA particles was formed at the
bone-HA interface. The initially deposited thin bone layer transformed and
remodeled into the mature bone during implantation time. As the HA particles can
integrate into bone with chemical bond [30, 31], it can be supposed that the porous
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PMMA-HA cement forms a superior dual chemical and mechanical bone-cement
interface compared with the porous PMMA cement. This meets our primary goal to
establish an enhanced fixation at the cement-bone interface for craniofacial bone
tissue repair to avoid the aseptic loosening of the cement. Future studies have to
prove that the incorporation of HA particles in PMMA cement indeed enhances the
mechanical fixation.
In the previous LQ YLYR study, micron-sized CaP particles were incorporated in
PMMA cement, which were found to become loosened from the pores and to trigger
an inflammatory reaction [17]. Consequently, we decided to investigate the
distribution modes of CaP particles of different sizes within porous PMMA scaffold LQ
YLWUR and found that millimeter-sized CaP particles become partially embedded in
PMMA and partially exposed to the pores [22]. The current data confirm that these
LQ YLWUR data can be safely extrapolated to the LQ YLYR situation. No loose HA particles
were seen in the histological sections and the HA particles were observed to be
fixed and maintained in the PMMA matrix. In addition, partially fixed HA particles
supported bone formation on the exposed HA surface. The HA particles did not
evoke a severe inflammatory response nor osteoclastic activity was observed. This
agrees with other studies [32, 33]. HA in sintered phase in this study is considered
to be very stable, which degrades very slowly [34, 35].
Regarding the defect bridging pattern, porous PMMA cement and porous
PMMA-HA cement showed different behavior at 4 weeks of implantation although
they got similar grading score. The explanation for this result can be, because the
inclusion of HA particles changed the original porous structure of cement. It has
been reported earlier that the scaffold architecture, i.e. porosity, pore size, plays a
crucial role in determining the rate and degree of bone ingrowth [36-38]. Extensive
studies led to the consensus that the optimal pore radius for bone ingrowth is at
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least 50 ȝm, but preferably as large as 150 ȝm [38]. Our previous studies proved
that porous PMMA had an average pore size larger than 150 ȝm and
millimeter-sized CaP particles significantly decreased the pore size to around 60 ȝm.
This means that the incorporated HA particles decrease the pore size of PMMA,
which influences the migration of cells and nutrient transportation pores [38, 39]. As
a consequence, a different defect bridging pattern between two cements will be
induced in the early stage of implantation. However, after prolonged implantation,
the continually growing bone will gradually interconnect and bridge the defect from
both the superior border to the interior border, as observed at 12 weeks of
implantation.
Thermal damage to bone or nerve tissues due to the exothermic polymerization
reaction of PMMA is a concern. The histological evaluation of the tissues in close
vicinity to the implanted cement, like defect borders and the mandibular nerve,
showed that both cements did not evoke a severe inflammatory response or
induced any damage to the tissues, which is consistent with the previous study [17].
This effect might be due to the contained CMC hydrogel, which acts as a heat sink
[16, 40]. Our previous study showed that the polymerization reaction temperatures
of porous PMMA and porous PMMA-HA were 32.37 and 28.23°C, which is lower
than the body temperature of 37 °C [23]. Further, it has to be noticed that only a very
small volume of PMMA was injected into the bone defect, which can be too small to
cause thermal damage to adjacent tissue. A test in a large defect model in large
animals is needed to confirm this.
No empty defect or autograft group were included as negative or positive control in
this study. The reason was that the current defect is not a critical sized defect, which
will heal spontaneously even without the installation of a grafting material. This
small defect model is adequate for an initial screening study, but it is necessary to
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further evaluate the porous PMMA-HA material in a critical sized defect model in
large animals including additional control groups.
 &RQFOXVLRQV
Both porous PMMA and porous PMMA-HA cement supported bone repair after
implantation in the rabbit mandible defect. Neither of them caused significant
inflammation to nerve or other surrounding tissues. After implantation of 12 weeks,
most of the porosity was filled by newly formed bone in both types of cement, which
supports the concept that a porous structure within PMMA can enhance bone
ingrowth. The PMMA-HA cement supported osteoconductivity into the cement
porosity and a direct bone-to-cement contact. Overall, the injectable porous
PMMA-HA might be a good candidate for craniofacial bone repair, which should be
further evaluated in a more clinically relevant large animal model.
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$EVWUDFW
Injectable polymethylmethacrylate (PMMA) bone cement is a widely used bone
substitute in cemented arthroplasty, vertebroplasty and osteoporosis fractures.
However, due to the inappropriate stiffness, poor bioactivity and high polymerization
temperature of PMMA, aseptic loosening of the implanted cement at the
bone-cement interface still could be observed in a high rate of patients. To improve
the performance of PMMA, arti¿cial extracellular matrices-like
chitosan-glycerophosphate (CS-GP) thermos-sensitive hydrogel was introduced
into PMMA acting as pore forming agent and osteoconductive nano-sized
hydroxyapatite (Nano-HA) /antibiotic gentamicin (GM) carrier. It is shown that
CS-GP thermo-sensitive hydrogel can effectively creat open pores at the surface of
PMMA cement, which is believed to facilitate bone tissue ingrowth and improve the
cement anchorage at the bone-cement interface in the future clinical applications.
Meanwhile, such hydrogel effectively decreases the maximum polymerization
temperature to below 30 ºC, prolongs the working time to more than 720 s and
produces cement with proper modulus of elasticity and the compressive yield
strength range from 402 to 584 MPa and from 3.1 to 5.9 MPa, respectively.
Furthermore, the incorporated Nano-HA particles sufficiently increase the
mineralization capacity of the cement without compromising its mechanical
properties and the incorporated GM remarkably enhance the anti-bacterial activity
of the cement. More importantly, Nano-HA and GM enriched CS-GP
thermo-sensitive hydrogel effectively improve the overall performance of PMMA
cement without influencing the cell survival, suggesting the injectable
p-PMMA/CS-GP/Nano-HA/GM cement will hold strong promise for future bone
reconstruction applications.
NH\ ZRUGV ˖ PMMA ˗ Gentamicin ˗ Hydroxyapatite ˗ Chitosan ˗
Glycerophosphate˗ Hydrogel
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 ,QWURGXFWLRQ
Bone is the unique tissue in the body that has the strong hardness and forms the
skeleton to support the whole body. Despite the fact that bone has the ability of
self-regenerating, it often can suffer from major biological and mechanical damages,
such as tumour, trauma or congenital disorders, which severely influence the
aesthetics, function and psychological well-being of patients.1, 2According to a
recent survey, the worldwide incidence of bone disorders and conditions has risen
sharply over the last decades and is expected to double by 2020.3 Therefore, the
effective bone grafting is necessary and important for the modern quality-of-life
expectations. In consideration of the serious disadvantages of donor limit, graft
rejection, pathogen transfer, and reimplant injury in conventional therapies, tissue
engineering strategy currently opens a new avenue for bone grafting, which utilizes
certain biomaterial as a three-dimensional bone substitute for the purpose of bone
repair and reconstruction.4 In the context of available materials for tissue
engineering, the injectable bone substitutes (IBSs) have become increasingly
attractive in bone grafting as they offer apparent advantages in view of minimally
invasive surgical procedures and effective ¿lling of complex- and irregular- shaped
defects with direct contact between biomaterial and surrounding tissue.5-7 From the
clinical perspective, the application of IBSs could alleviate patients’ discomfort,
shorten the recovery time and reduce the treatment cost.8
Polymethylmethacrylate (PMMA) or known as “bone cement” is a specialized form
of IBS to fix the prosthetic devices for more than 50 years. Until now, PMMA is still a
widely used IBS in cemented arthroplasty, vertebroplasty and osteoporosis
fractures.9-11 Although such material has been extensively applied due to its easy
handling characteristics, good moldability, sufficient strength, low price and
FDA-approved,12, 13 it is associated with several unfavorable properties. Aseptic
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loosening of the implanted PMMA at the cement-bone interface was observed in a
high rate of patients due to its inappropriate stiff properties and the poor bioactivity.
Thermal necrosis caused by PMMA polymerization resulted in the tissues damage
around cement surface. Moreover, the infection of the PMMA caused a number of
prosthesis removal in the clinic.14-16 These behaviors signi¿cantly restrict the new
bone growth at the bone-cement interface. To circumvent these problems,
modifications of PMMA have been performing to improve the PMMA based
cement-bone interactions.10, 12, 15, 17
Previous studies confirmed that creating the open porosity was an effective strategy
to improve the performance of implanted solid material since the interconnected
porous scaffold was believed to relieve the stiffness of material and promote the
tissue ingrowth, thereby creating more interlocking and the mechanical anchorage
at the bone-material interface.4, 12, 18, 19 Van muller and de Wijn HW DO developed the
porous PMMA (p-PMMA) by mixing the separated hydrophobic PMMA phase with
hydrophilic carboxymethylcellulose (CMC) hydrogel phase.18, 20, 21 They found the
CMC hydrogel was responsible for creating the porosity and the bone indeed grew
into the p-PMMA scaffold.20, 21 To modify this system enabling to further improve the
performance of p-PMMA, our research group tried to incorporate osteoconductive
CaP materials into the CMC hydrogel LQ YLWUR and LQ YLYR.10, 15, 22 The LQ YLWUR study
showed that the CMC hydrogel contributed to relieving the stiffness and reducing
the risk of thermal necrosis of PMMA material. More importantly, the incorporated
CaP provided PMMA cement with potential osteoconductivity without compromising
beneficial mechanical properties and the low polymerization temperature of
p-PMMA.10, 15 However, the following LQ YLYR study revealed that the addition of CaP
particles did not increase the amount of bone formation and ingrowth at the
bone-cement interface.22 The micro-sized ȕ-TCP particles which were embedded in
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CMC gel previously was found to trigger the host inflammatory response and
influence the chemical bonding to bone LQ YLYR 22 That suggested the way by which
the CaP particles were included into the PMMA matrix previously restricted the
osteoconductive advantage of cement. Therefore, new combination of CaP particle
and pore forming agent should be further selected and tested to optimize the
osteocompatibility of p-PMMA/CaP cement at the interface. In addition to this, since
the bone substitute capable of local antibiotic delivery could improve the success
rate in revision cases and antibiotic-loaded PMMA cement is becoming the standard
practice for preventing infection in joint arthroplasty and for treating infection in
osteomyelitis, 11, 14 antibiotic also need to be considered as an essential component
to incorporate into the p-PMMA/CaP system.
To better improve the performance of bone substitute at the bone-material interface,
it is preferable to develop biomaterials mimicking the composition and structure of
bone in the local sites.23 Therefore, biomimetic ways to combine arti¿cial
extracellular matrices (ECMs)-like hydrogel and nano-sized CaP as a temporary
three-dimensional (3-D) environment, which is suitable for suitable cells
colonization and eventual tissue regeneration, are currently being broadly explored
in the field of chemistry and bone tissue engineering.24-26
Chitosan (CS), the unique aminopolysaccharide derived from abundant chitin in the
nature, is obtaining great interest for various biomedical applications due to its
non-toxic,27, 28 biodegradable,29, 30 and anti-bacterial abilities.31, 32 Glycerophosphate
(GP), an organic compound naturally found in the body, is utilized in treating the
unbalance of phosphate metabolism and some type of GP, such as ȕ-GP, has
proved acting as an osteogenic supplement when added to cultures of human bone
marrow stem cells.33 Recently, an injectable CS-GP based thermo-sensitive
hydrogel was developed and has been becoming more and more attractive in IBS.33
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Such hydrogel could rapidly change their equilibrium swelling via the multiple
interactions between CS, ȕ-GP and water under the stimuli of temperature and then
form non-free-Àowing gel at body temperature (37 ºC) from the original solution
state.34 In addition, it possesses appealing properties, e.g. injectability,
biocompatibility, biodegradability and ability to act as ECM. More importantly, it can
serve as a promising carrier for LQ VLWX release of pre-incorporated osteoconductive
CaP particles and pre-loaded drug.31, 33, 35 Therefore, CS-GP thermo-sensitive
hydrogel could be regarded as an ideal pore forming agent and nano-sized
CaP/drug carrier to mimic the mineral component and nanostructure of natural bone
at the cement-bone interface. But to the best of our knowledge, no attempt to
combine PMMA and CS-GP based thermo-sensitive hydrogel has been reported.
In this study, CS-GP hydrogel was prepared to generate opened and interconnected
pores within PMMA. Moreover, osteroconductive nano-sized hydroxyapatite
(Nano-HA), which was prepared to mimic the nano-crystals within bone structure,36
or gentamicin (GM), which was used as a broad-spectrum antibiotic for treating
infection or osteomyelitis,37 or a combination of them was preloaded into the CS-GP
thermo-sensitive hydrogel to modify the bulk properties of the cement. The objective
of the present study was to develop a novel injectable PMMA/CS-GP/Nano-HA/GM
cement with easy handling property, safe polymerization temperature, adequate
biocompatibility, proper mechanical performance, favorable biomineralization
capacity and effective infection-resist ability for the future clinical bone
reconstruction.
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 (;3(5,0(17$/ 6(&7,21
 0DWHULDOV
A two-component (powder and liquid) PMMA kit (Self-curing PMMA, type II) was
purchased from Shanghai New Century Dental Materials Co. (Shanghai, China).
The solid component consisted of PMMA, dibenzoyl peroxide (BPO), silicon dioxide
and barium sulfate powders. The liquid part was a mixture of methylmetacrylate
(MMA) solution and N, N-dimethyl-p-toluidine (DMPT) solution. BPO was used as
initiator and DMPT was used as accelerator for the polymerization reaction. Silicon
dioxide was used as reinforcer and barium sulfate was used as radiopaque agent.
Ca(NO3)2·4H2O, (NH4)2HPO4 and NH4OH were purchased from Aladdin Co., Ltd.
(Shanghai, China). Chitosan (CS) (Mw =179.17 kD; N-deacetylation rate of  95%;
viscosity = 100-200 mPa.s) was purchased from Aladdin Co., Ltd. (Shanghai,
China). ȕ-GP (Mw =216.04 g/mol) was obtained from Sigma-Aldrich (Sigma-Aldrich,
USA). GM sulfate (Mw = 547.6207 g/mol, potency 590 μg/mg) was purchased from
Amresco (Amresco, USA). All other chemical reagents were of analytical grade or
better.
 3UHSDUDWLRQ DQG FKDUDFWHUL]DWLRQ RI 1DQR+$ FU\VWDOV
Nano-HA was synthesized as our previously described.38 20 ml of 1.08 M
Ca(NO3)2·4H2O (pH=10, adjusted by NH4OH) was heated to 90 ć and 20 ml of
0.65 M (NH4)2HPO4 solution was subsequently added drop-wise under stirring. The
precipitate was maintained in contact with the reaction solution for 5 h at 90 ć
under stirring, and then centrifuged at 1800 J for 10 min. After that, the precipitate
was repeatedly washed with distilled water (DW) and centrifuged for 6 times, then
dried at 37ć overnight.
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The morphological investigation of the synthesized HA precipitate was performed
by scanning electron microscope (SEM) (Sigma, Zeiss, Germany) and transmission
electron microscope (TEM) (JEM-2100, JOEL, Japan). The crystal phase of
synthesized precipitate was analyzed by X-ray diffraction (XRD, X' Pert Pro, The
Netherlands) with a wavelength of 1.5406 Å at a voltage of 40 kV and a current of
40 mA. XRD patterns were collected for 2ș values between 10° and 80° in a
continuous mode at a rate of 25 seconds per step and a step size of 0.026° (2ș).
 3UHSDUDWLRQ RI WKH FHPHQWV
In this study, CS-GP thermo-sensitive hydrogel was firstly prepared according to the
method of Zhao HW DO .39 In brief, 0.9 g CS powder was dissolved into 4.5 ml 0.1 M
hydrochloric acid solution with stirring under room temperature until the complete
dissolution of the powder, then the CS solution was chilled at 4ć for 15 min.
Similarly, 0.5 g ȕ-GP liquid was dissolved in DW to a concentration of 50% (w/w)
under room temperature and then chilled at 4ć along with the chitosan solution.
Subsequently, ȕ-GP solution was added into CS solution drop-wise under stirring
and the CS-GP solution was mixed for another 20 minutes. Then gel-forming
process of the solution was conducted in the thermostat at 37ć for 5 min. To
prepare the Nano-HA or GM-loaded thermo-sensitive hydrogel, 300 mg Nano-HA or
25 mg GM or a combination thereof was added into the homogeneous CS-GP
solution, respectively. The whole solution was mixed uniformly by using sonication
and then transformed into the hydrogel at 37ć for 5 min ()LJ).
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)LJ.Different status of CS-GP solution at room and body temperature. All groups of CS-GP solution
remained liquid at room temperature (23.6ć) and transformed into semisolid hydrogen at body
temperature (37ć).
7DEOH listed the needed raw materials for the cement. To prepare plain PMMA
cement, PMMA kit powder part and PMMA kit liquid part were manually blended
with the weight ratio of 1:1 (powder weight to liquid weight) until a homogeneous
paste was obtained. Subsequently, the mixture was injected into the Teflon mould (6
mm in diameter; 12 mm in height) to form the cylinder-shaped samples. To prepare
the p-PMMA cement, the mixed PMMA phase was further blended with CS-GP
hydrogel with a volume ratio of 3:4 until a homogeneous paste was obtained. To
prepare the Nano-HA or GM incorporated cements, Nano-HA or GM pre-loaded
CS-GP hydrogel was mixed with PMMA paste until a homogeneous mixture was
reached. The rest of the process was the same with that of plain PMMA preparation.
The schematic diagram of the synthesis of p-PMMA-based cements was shown in
)LJ . After curing overnight, samples were unmoulded, DW washed, freeze-dried
and imaged by a Nikon D3100 digital camera.
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Fig.2. The schematic diagram of the synthesis of p-PMMA-based cements.
Table 1. Compositions of the prepared cements.
Plain
PMMA
p-PMMA
/CS-GP
p-PMMA
/CS-GP
/Nano-HA
p-PMMA
/CS-GP
/GM
p-PMMA
/CS-GP
/Nano-HA/GM
6ROLG FRPSRQHQW J
PMMA 3 3 3 3 3
CS 0 0.09 0.09 0.09 0.09
ȕ-GP 0 0.5 0.5 0.5 0.5
HA 0 0 0.3 0 0.3
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Plain
PMMA
p-PMMA
/CS-GP
p-PMMA
/CS-GP
/Nano-HA
p-PMMA
/CS-GP
/GM
p-PMMA
/CS-GP
/Nano-HA/GM
GM 0 0 0 0.025 0.025
/LTXLG FRPSRQHQW PO
MMA 1.5 1.5 1.5 1.5 1.5
DW 0 0.5 0.5 0.5 0.5
 7KHUPDO SURSHUWLHV DQG ZRUNLQJ WLPH
The polymerization temperature of cement was monitored at room temperature of
23.6ć by a type K thermocouple (Victory high electronic technology co., China)
connected to a data logger (Victor E86, Victory high electronic technology co.,
China). Once the homogeneous mixture was packed into the mould, the probe of
the thermocouple was located at the center of the cement surface according to the
previous study .15 The maximum temperature (Tmax) was obtained during the
polymerization reaction (n=3). Further, the working time was recorded, which was
defined as the time between the material could be safely injected into a cavity to the
material becomes too stiff to inject through the access needle.40
 &7 DQDO\VLV
Micro-computed tomography (μ-CT 50, Scanco Medical, Basersdorf, Switzerland)
was used to examine the porometrical properties and particle distribution of
Nano-HA within the PMMA matrix. A representative cement from each group was
placed in a custom-made holder to ensure that the long axis of the cement was
oriented perpendicular to the axis of X-ray beam. A pixel of 12 μm, with acquiring
conditions of 90 kV and 88 μA in high resolution mode were used. About 900 slices
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per cement were used to reconstruct the images.
 3RURVLPHWU\
The porosity and pore size distribution of cements were evaluated by mercury
intrusion porosimeter (MIP; AutoPore IV 9500, Micrometrics, USA). Three
freeze-dried cements from each group were introduced into the penetrometer
placed in the low-pressure chamber of the porosimeter and filled with mercury for
evaluation. The MIP test was performed at a pressure range from 0.0010 to
228.0000 MPa. The relation between pressure p (MPa) and the pore diameter d
(μm) was determined by the classic Washburn equation 41 on the basis of a model
for cylindrical pores:
݌ ൌ െ Ͷߛܿ݋ݏߴ݀
where Ȗ is the surface tension of the mercury and ș is the contact angle between the
mercury and the pore surface of PMMA. In this study, the Hg surface tension,
contact angle of mercury and Hg Density were 485.000 dynes/cm, 130° and
13.5335g/mL, respectively.
 $QWLEDFWHULDO DFWLYLW\ DVVD\
GM sulfate within the prepared cement was confirmed by detecting S 2p of X-ray
photoelectron spectroscopy (XPS; Kratos XSAM 800, Britain) with an Al KĮ X-ray
source (1486.6 eV). The cements were mounted on cement stubs with conductive
carbon tape. The take-off angle was fixed at 90° and the pressure in the analysis
chamber was 2×10-7 Pa. The selected resolution for the general spectra was 100.0
eV of Pass Energy and 1.0 eV/step. The spectra of S 2p were then collected at
Pass Energy of 20.0 eV and a step size of 0.05 eV. Finally, XPS results were
analyzed by XPSPEAK41 software after the subtraction of a linear baseline.
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Disk-diffusion method was used to investigate the inhibitory effect of the CS-GP
based hydrogel against Escherichia coli. 30 μl of the Escherichia coli suspensions
over the range of 0.05-2 mg/ml were pipetted onto petri dishes containing
Luria-Bertani agar culture medium and then distributed evenly. CS-GP hydrogel,
CS-GP/Nano-HA hydrogel, CS-GP/GM hydrogel and CS-GP/Nano-HA/GM
hydrogel were freeze-dried and pressed into discs (Diameter = 13mm). Then these
discs were separately placed onto the semi-solid culture medium for 16 hours
incubation at 37°C. After that, the anti-bacterial activities of the prepared
composites were evaluated by measuring the zone of inhibition (ZOI), which was
defined as the clear region around the disc saturated with an antimicrobial agent on
the agar surface. Each sample was repeated three times.
 ,Q YLWUR F\WRWR[LFLW\ PHDVXUHPHQW
3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay was
carried out to determine the LQ YLWUR short-term cytotoxicity of the prepared cements.
Firstly, MC3T3 cells were routinely cultured in the medium of a-MEM (Hyclone, USA)
which was supplemented with 10% fetal bovine serum (FBS; Hyclone, USA), 1%
penicillin (100U/ml) and 1% streptomycin sulphate (100 mg/ml). Then, 200 μl
MC3T3 cells were seeded into 96-well microplates at a density of 1×104/well and
incubated in a humidified incubator containing 5% CO2 at 37 ć. After 24 h
incubation and attachment, the culture medium was aspirated and replaced with
extract solutions (n=6). Extracts solutions were prepared by incubating the
autoclaving PMMA-based cements in culture medium for 72 h at 37 ć and the ratio
between the mass of cements and the final volume of extracts was approximately
0.2 g/ml according to ISO 10993 standard 42. Standard culture medium alone was
served as the negative control. After designed time points (1 d, 3 d), 20 μl MTT
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(Sigma, USA) solution (5mg/ml) was added to each well, followed by further
incubationfor4h.Subsequently,MTTmediumwasremovedbyaspirationandthe
formed formazancrystalsweresolubilizedby200μldimethylsulphoxide (DMSO;
Amresco,USA)withgentlyshaking in thedark for15min.Lastly,theabsorbance
wasmeasuredusinganautomatedplatereader(PowerwaveXS2,Biotek,USA)at
awavelengthof490nm.Therelativegrowthrate(RGR)wascalculatedbasedon
the following equation corresponding to cytotoxicity level: RGR = ODsamples /
ODnegativecontrol×100%.42
6LPXODWHGERG\IOXLG6%)LPPHUVLRQ
In order to assess the reaction of different PMMA cements in physiological
conditions,SBFwas prepared according to the protocol ofKokubo HW DO.43 The
comparison of ion concentrations between SBF and human blood plasma was
showninTable2.TheLQYLWURimmersiontestwascarriedoutbyimmersingcement
inSBF(10mlSBFforeachcement)at37ć,whichwasrefreshedweekly.After28
days,cementswerewashedinDW,freeze-dried,andusedforthefollowingstudies
alongwiththecontrolcementswhichwasnotimmersedinSBF.
7DEOH  Ion concentrations, in nM, of SBF and human blood plasma
1D . &D 0J &O 62 +&2 +32
6%)        
+XPDQ EORRG SODVPD        
0LQHUDOL]LQJFDSDFLW\RIFHPHQWV
SEM (Sigma,Zeiss,Germany)wasused to analyse the internal structure of the
freeze-dried cements before and after immersion in SBF.The cross sections of
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fracturedcementsweremountedonaluminumstubsusingconductivecarbontape
andsputtercoatedwithgold.Thenthemorphologyofcementswasexaminedatan
acceleratingvoltageof5kVandworkingdistanceof4-8mm.
X-rayDiffraction(XRD;X'PertPro,TheNetherlands)analysiswereusedtomonitor
thecompositionpresent inthePMMAcementsbeforeandafterimmersioninSBF.
Theanalysiswasperformedupontheflatsurfacesofcementsandtheparameters
werethesamewiththoseofNano-HAcharacterization.
0HFKDQLFDOSURSHUWLHV
Themodulusofelasticity (E)and thecompressiveyieldstrength (ıy)ofcements
were determined using a tensile bench (MTS810, MTS Systems co., USA).
According to the International Standardization Organization (ISO) ISO 5833, 6
mm×12mmcylindricalcements(n=3)werecompressedalong their longaxisata
cross-headspeedof0.5mm/min.Unliketheothertests,themechanicalproperties
wereperformedimmediatelyaftersoakinginSBFwithoutintermediatedryingofthe
cements.
6WDWLVWLFDODQDO\VLV
A one-way analysis of variance (ANOVA) was used to determine the statistical
signi¿cance followed by SRVW KRF analysis using the Turkey test (SPSS 16.0).
Resultswereconsideredsignificantlydifferentatp<0.05.
5(68/76$1'',6&866,21
&RQILUPDWLRQRISUHSDUHG1DQR+$
)LJDfromXRD identifiesthecrystallinedepositbymainreflectionpeaksforHA
(25.8, 31.8, 32.2, 32.9 and 34.0 2ș). )LJ EF reveal needle-shaped HAwith
averagediameterand lengthof30±5nmand100±20nm fromcomplementing
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SEM and TEM observations. Since bone mainly consists of calcium phosphate
nanocrystals (~70 wt%), the prepared Nano-HA mimics the mineral component of
bone with potential ossteoconductive capacity.8, 24
)LJ Characterizations of Nano-HA particles. (a)XRD analysis, (b) SEM observation, and (c) TEM
observation
 7KHUPDO SURSHUWLHV DQG ZRUNLQJ WLPH
In this study, we successfully transformed the CS-GP liquid into semisolid hydrogel
at physiological conditions (pH = 7, Temperature = 37ć) and synthesized p-PMMA
based cements LQ YLWUR by easily mixing the separated hydrophobic PMMA phase
and hydrophilic CS-GP phase. The Tmax of plain PMMA cement is found to reach up
to nearly 80°C 7DEOH , which is consistent with the results of previous studies.44-46
However, it is interesting to note that all the p-PMMA based groups show no
obvious exothermic reaction with Tmax varied from 26.7 to 28.3ć 7DEOH . No
significant difference is found among different p-PMMA based groups (p > 0.05)
Such result may be attributed to the lower volume density of MMA monomers and
higher CS-GP hydrogel in p-PMMA based cements in comparison with those in
plain PMMA cement. Therefore, all the p-PMMA based cements mitigate the risk for
thermal necrosis to the surrounding tissues. More importantly, the effects of
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Nano-HA and GM will not be weakened by the polymerization-induced heat during
the cements applications.
Since the amount of released heat is closely associated with the polymerization
speed of PMMA, the lower Tmax of p-PMMA based cements resulted in their longer
working time. It is found that the working time of p-PMMA based cements varied
from 723 to 773 s with no significant difference among groups (p > 0.05), which is
significantly longer than that of plain PMMA around 516 s (p < 0.01) 7DEOH . Such
result indicates an important clinical significance that surgeons will have enough
time to effectively inject the p-PMMA based cement into the complex- and irregular-
shaped bone defects without additional techniques in the conventional plain PMMA
treatment, such as pre-cooling the cement or decreasing the operation room
temperature, to extend the polymerization process 47.
7DEOH  Mean values of Tmax and working time of the prepared cements
Group Tmax(ć) Working timeδSε
PMMA 76.9±0.5 516±1.8
p-PMMA/CS-GP 28.3±0.3 723±0.9
p-PMMA/CS-GP/Nano-HA 27.8±1.2 773±1.5
p-PMMA/CS-GP /GM 28.0±0.8 756±0.2
p-PMMA/CS-GP/Nano-HA/GM 26.7±1.0 739±1.3
 0RUSKRORJ\ DQG SRUH SDUDPHWHUV
The surface morphologies of prepared cements are shown in )LJ $. In
comparison with plain PMMA, numerous pores are found on the surface of p-PMMA
based cements. Further, the incorporated Nano-HA particles in white colour are
aggregated within the porosities as expected. Since the osteoconductive HA
particles can form a direct chemical bond with bone, 17 HA-loaded cements are
expected to show better effects for the future bony conjunction when compared with
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HA-free cements.
The 3D reconstruction images and cross-sectional view from μ-CT are used to
indicate the bulk morphology of the cement, internal porous structure of PMMA
matrix and the incorporated Nano-HA particles ()LJ %&). For the plain PMMA
cements, only few pores can be seen outside and inside of the cements. In contrast,
the p-PMMA/CS-GP and p-PMMA/CS-GP/GM cements reveal similar irregular
porous structures with interconnected channels. For the p-PMMA/CS-GP/Nano-HA
and p-PMMA/CS-GP/Nano-HA/GM cements, Nano-HA particles fill the
interconnected pores as agglomerated phases. SEM observations at low
magnification (250×) further display the general morphologies of cross-sectional
cements ()LJ '). For the plain PMMA, globular-like MMA particles connect with
each other to form the dense structure of PMMA. In comparison, interconnected but
irregular porous structures are seen within the other p-PMMA based cements.
)LJ Morphology of the CS-GP hydrogel and prepared cements (A) Surface morphologies;
(B,C)μ-CT graphs and (D)SEM observations at low magnification
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The detailed porosity results are shown in )LJ D. The porosity with a pore size
larger than 10 μm for the PMMA, p-PMMA/CS-GP, p-PMMA/CS-GP/Nano-HA,
p-PMMA/CS-GP/GM and p-PMMA/CS-GP/ Nano-HA /GM are 0.2%, 8.2%, 5.3%,
10.6% and 5.6%, respectively. Furthermore, the porosity of cements decreases
along with the increased pore size. The pore size distribution curve is shown in )LJ
E. The peaks representing the average pore diameters correspond to pore sizes of
6 μm, 76.5 μm, 88.4 μm, 77.8 μm and 69.9 μm for PMMA, p-PMMA/CS-GP,
p-PMMA/CS-GP/Nano-HA, p-PMMA/CS-GP/GM and p-PMMA/CS-GP/ Nano-HA
/GM, respectively ()LJ E).
)LJPorometric properties of PMMA-based cements: a. porosity; b. pore-size distributions.
The morphology and MIP results both reveal that only a few separated pores were
involved in plain PMMA due to the introduction of air during the plain PMMA
preparation. In contrast, open porosities with pore interconnectivity are found in
p-PMMA based cements. Although p-PMMA/CS-GP/Nano-HA cement and
p-PMMA/CS-GP/Nano-HA/GM cement both show decreased porosities in
comparison with p-PMMA/CS-GP cement and p-PMMA/CS-GP/GM cement due to
the incorporation of Nano-HA particles, all the p-PMMA based cements prove that
CS-GP hydrogel formed a continuous phase after preparation of the cement. It is
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known that the hydrogel mimics the native ECM both in mechanical and
compositional properties.33, 48 Therefore, the CS-GP hydrogel can serve as a
supporting network in cements for cells during tissue regeneration, which is
believed to benefit the future bone ingrowth into the cement LQ YLYR.
 (YLGHQFH RI $QWLEDFWHULDO DFWLYLW\
The XPS spectra confirm the successfully incorporated GM sulfate in group
p-PMMA/CS-GP/GM and group p-PMMA/CS-GP/Nano-HA/GM by identifying the
single type of S 2p at the binding energy about 168.5 eV. However, no obvious S 2p
peak is found in group plain PMMA ()LJ $). The inhibition abilities of the CS-GP
based hydrogels are shown in )LJ % It is found that all the measured plates show
the translucent zone against (VFKHULFKLD FROL. Furthermore, group
p-PMMA/CS-GP/GM and group p-PMMA/CS-GP/Nano-HA/GM display greater
diameters of ZOI (4.58 cm and 4.39 cm, respectively) than those of
p-PMMA/CS-GP and p-PMMA/CS-GP/Nano-HA (0.35 cm and 0.29 cm, respectively)
()LJ %). No statistical significance is found between group p-PMMA/CS-GP and
group p-PMMA/CS-GP/Nano-HA (p > 0.05) or between p-PMMA/CS-GP/GM and
group p-PMMA/CS-GP/Nano-HA/GM (p > 0.05). Such result indicates that CS
component involved in CS-GP hydrogel indeed plays a certain part in the
antibacterial activity. But the addition of GM remarkably enhances the antibacterial
activity of the cement suggesting the better infection control abilities of GM loaded
cements in future LQ YLYR applications.
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)LJ Evidence of antibacterial activity of cements (A) XPS spectra of S 2p for the solid PMMA and
GM-loaded PMMA cements; (B)Antibacterial activity of disc-like samples by Zone of inhibition (ZOI)
test against E.coli: a. CS-GP; b. CS-GP/Nano-HA; c. CS-GP/GM; d. CS-GP/Nano-HA/GM.
(Translucent zones indicated inhibition of bacterial growth).
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 ,Q YLWUR F\WRWR[LFLW\ PHDVXUHPHQW
To better adapt the LQ YLYR circumstance, the cytotoxicity of cement is also of great
concern. The results are shown in 7DEOH . It is evident that the OD values increase
with the culture time for all the cements. Accordingly, the RGR of MC3T3 cells are
higher than 100% in the presence of all cements both in the 1st day and the 3rd day.
There is no statistically significant difference among all groups as compared to the
control (p > 0.05). Such result proves that plain PMMA supports the cell viability,
which is consistent with previous studies that PMMA showed no cytotoxicity.17 More
interestingly, the addition of CS-GP, Nano-HA and GM did not influence the cell
survival, suggesting the modifications of plain PMMA could remarkably improve the
overall performance of cements without disturbing the cell viability
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  3OTKXGRO`OTM IGVGIOZ_ UL IKSKTZY
SEM observations in high magnifications (20,000×) confirm the mineral formation
abilities of the cements ()LJ $). Before immersion, group PMMA show clear
surface of PMMA matrix. Group p-PMMA/CS-GP and group p-PMMA/CS-GP/GM
display uniformly formed CS/GP films covering the PMMA matrix. Group
p-PMMA/CS-GP/Nano-HA and group p-PMMA/CS-GP/Nano-HA/GM reveal the
incorporated needle-like Nano-HA crystals lay on the CS-GP films. After immersion
in SBF for 28 days, no obvious change is found in group PMMA and only a few
granular precipitates are distributed on the surface of PMMA matrix in group
p-PMMA/CS-GP and group p-PMMA/CS-GP/GM. In contrast, abundant and bigger
ball-like precipitates form a layer on the surfaces of needle-like Nano-HA crystals as
well as the surface of PMMA matrix in group p-PMMA/CS-GP/Nano-HA and group
p-PMMA/CS-GP/Nano-HA/GM ()LJ $)
)LJ % presents the detected crystal phases from XRD analysis before and after
immersing cements in SBF. Before immersion, a typical peak corresponding to
barium sulfate (at 27.0° 2ș) is detected for all the cements and a typical peak
corresponding to HA is identified (at 32.0° 2ș) for the HA loaded cements. After
immersion for 28 days, no obvious change is observed for group PMMA. A peak
assigned to the reflection of an apatite-like phase (at 31.9° 2ș) is identified for all
p-PMMA based groups.
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)LJ Mineralizing capacity of cements. (A) SEM images (×20000) and (B)XRD patterns of
PMMA-based cements before and after immersion in SBF for 28 days
Taking inspiration from the mineral component of natural bone, a carbonated apatite
nanocrystal, we incorporated Nano-HA into the CS-GP hydrogel to facilitate the
mineral-forming ability. SEM observations and XRD identification prove that plain
PMMA did not interact with SBF and Nano-HA free p-PMMA cements only showed
slight interaction with SBF. These phenomena agree with previous study where
plain PMMA was bionert and CS incorporation induced the formation of a few
apatitic precipitates onto the surface of PMMA due to the CS composition and the
beneficial surface roughness as well as the wettability of PMMA perfected by CS 49.
In contrastˈNano-HA loaded p-PMMA show agglomerations of Nano-HA particles
within the porosities after preparation. Further, a dense ball-like apatite layer forms
on the surface of Nano-HA particles after immersion in SBF for 28 days. It is known
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that some bioactive IBS, like calcium phosphate cement, show ability of forming
apatite-like structure in the SBF.10 Evidently, SEM and XRD results prove that
effectively incorporated osteoconductive Nano-HA particles provide better mineral
forming ability of cements, which evidently improve the potential bioactivity of
injectable p-PMMA/CS-GP/Nano-HA/GM cement for future LQ YLYR bone-bonding in
comparison with injectable bionert PMMA.
 0HFKDQLFDO SURSHUWLHV
Mechanical results are displayed in )LJ . Before immersion, plain PMMA cement
show E of 5107.31 MPa and ıy of 62.31MPa. p-PMMA based cements reveal the E
values range from 402 to 584 MPa and ıy values range from 3.1 to 5.9 MPa. The E
and ıy values of PMMA cement are significantly higher than those of p-PMMA
based cements (p < 0.001). No significant difference of E and ıy is found among
p-PMMA based cements (p > 0.05). After immersion in SBF for 28 days, no
statistical significance is found between the two time points regarding both ıy and E
for all the groups (p > 0.05).
)LJ Mechanical properties of PMMA-based cements before and after immersion in SBF for 28
days. (I). PMMA; (II). p-PMMA/CS-GP; (III). p-PMMA/CS-GP/Nano-HA; (IV). p-PMMA/CS-GP/GM;
(V). p-PMMA/CS-GP/Nano-HA /GM. a. Modulus of elasticity (E); b. Compressive yield strength (ıy).
(* shows significant difference between plain PMMA and other groups regarding E or ıy, P < 0.05.
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Mechanical properties play influential roles in determining the long-term stability of
biomaterials. Due to this, the stiffness of plain PMMA makes the poor bone-PMMA
integration which causes the occurrence of interface fractures.10 Furthermore, the
weak strength of the hydrogel restricts its application only in cartilage
reconstructions or small bone defects under the non-load-bearing condition 8, 31.
However, the mechanical results in the present study reveal the interesting
compromise between plain PMMA and CS-GP hydrogel. All the p-PMMA based
cements well match the strength and stiffness of cancellous bone (50~800 MPa of E
and 4~12 MPa of ıy, respectively),50, 51 which are significantly lower than injectable
plain PMMA but higher than injectable hydrogels. 52-54 Further, since the mechanical
properties of p-PMMA cements are mainly determined by PMMA SHU VH and pore
forming agent 10,12,15 and the addition of Nano-HA or GM or a combination thereof
within the pore forming agent do not significantly influence the amount of CS-GP
hydrogel, all the modified p-PMMA cements show similar bulk mechanical
properties which will be highly beneficial in view of possible stress shielding effects
and corresponding reduction of the fracture risk when compared with conventional
plain PMMA of much higher strength and stiffness.55,56
 &21&/86,21
The present LQ YLWUR study demonstrates that the appropriate selection of instructive
components is the key strategy to improve the properties of constructed cements.
Speci¿cally, CS-GP thermo-sensitive hydrogel creates open pores at the surface of
PMMA cement, which is believed to facilitate bone tissue ingrowth and improve the
cement anchorage at the bone-cement interface in the future clinical applications.
Furthermore, CS-GP hydrogel decreases the Tmax, prolonged the working time, and
make appropriate mechanical properties of cements. Enriched Nano-HA particle
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within hydrogel enhances the mineralization capacity of the cements without
compromising their mechanical properties. Enriched GM within hydrogel improves
the anti-bacterial activity of cements, which will benefit the prevention of infections.
Ultimately, Nano-HA and GM enriched CS-GP hydrogel increase the overall
performance of PMMA cement without influencing the cell survival, suggesting the
injectable p-PMMA/CS-GP/Nano-HA/GM cement would hold strong promise for
future bone reconstruction applications.
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 6XPPDU\
Polymethyl methacrylate (PMMA) has been widely used in clinic as a bone graft
substitute. However, long-term clinical observations have indicated that PMMA
cement is also beset with some drawbacks, including risk of infection, unsatisfactory
bioactivity, venture of fractures and strong exothermic reactions. This PhD thesis
focused on the modification of PMMA to improve its clinical performance. To this
end, a general introduction on bone defect and PMMA modification as well as a
brief description of the objectives of this thesis was provided in &KDSWHU .
To overcome the aforementioned shortcomings of PMMA, numerous additives were
utilized to address the problems of plain PMMA over the last decades. &KDSWHU 
provided an overview of the use of additives and aimed to provide information for
future PMMA application in orthopedic surgery, with specific emphasis on
modifications to the common complication of aseptic loosening, infection of the
prosthesis and thermal necrosis to the surrounding tissue in the clinic. Six types of
additives, i.e.: 1) bioceramic additives; 2) filler additives; 3) antibiotic agents; 4)
porogens, 5) biological agents and 6) mixed additives have been reported to be
loaded into PMMA cement to improve its performance. Mixed additives seem the
most suitable choice aiming to create a multifunctional cement to fulfill the clinical
requirements. Studies proved the beneficial effect of porous PMMA cement on bone
ingrowth, drug release and as space maintainer in the field of reconstructive surgery.
Further, an elaborated and improved selection of functional additives would further
enhance the targeted function of porous PMMA based cement.
The following chapters of this thesis focused on the behavior of porous
PMMA/calcium phosphate (CaP) based cements LQ YLWUR and LQ YLYR
&KDSWHU  evaluated whether CaP particles could be loaded into porous PMMA and
how these particles influenced the bulk physicochemical properties and bioactivity
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of the cement under simulated physiological conditions. This study demonstrated
that CMC hydrogel was responsible for the creation of porosity and interconnectivity
and the addition of CaP did not affect these pore parameters and did not influence
chemical composition or the mechanical properties of PMMA. When cements were
immersed in simulated body fluid, the CaP particles in the porous phase were able
to interact with the surrounding environment and to increase the potential bioactivity
of cements. Mechanical properties were not significantly altered by the CaP
percentages or the immersion time.
In a previous study [1], it was speculated that the size of the CaP particles might
also influence the final LQ YLYR performance of PMMA/CaP cement. To further
optimize the osteocompatibility of porous PMMA/CaP cements, two different size of
CaP ceramics were loaded into porous PMMA in &KDSWHU  The physicochemical
properties and mineralization capacity of cements were evaluated It was found that
both small micron-sized CaP and large millimeter-sized CaP could be successfully
loaded into PMMA cement exhibiting an interconnected porosity created by mixing
with CMC. The incorporation of CaP particles did not influence the maximum
polymerization temperature of the porous PMMA, but reduced the porosity and the
average pore size. Both types of CaP particles enhanced the mineralization
capacity of PMMA cement without compromising their mechanical properties as
demonstrated by simulated body fluid (SBF)immersion. Small micron-sized CaP
particles formed agglomerations within the PMMA pores, whereas the large
millimeter-sized CaP particles were partially embedded in the PMMA matrix and
partially exposed to the pores for potential bone contact.
In FKDSWHU , the effect of millimeter-sized CaP particles and CMC porogen on bulk
physicochemical properties and potential bioactivity of porous PMMA cement were
evaluated for future clinical use. It was demonstrated that the incorporation of CMC
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hydrogel decreased the maximum temperature of cement to the normal body
temperature and prolonged the handling time during polymerization. Further, the
amount of CMC was responsible for the creation of porosity and interconnectivity,
which in turn determined the final mechanical properties of the cement. More
interestingly, the increased amount of CaP particles enhanced the biomineralization
ability of the composite without weakening its mechanical property.
The performance of the LQ YLWUR optimized porous PMMA based composite was
assessed LQ YLYR in &KDSWHU . In this chapter, the performance of porous PMMA
cement and porous PMMA cement loaded with a high amount of millimeter-sized
HA particles (PMMA-HA) were evaluated and compared in a rabbit mandibular
defect model. Local tissue response, recovery of the bone defect, and bone
ingrowth within the porosity of the PMMA implants were histologically evaluated
after 4 and 12 weeks of implantation. Results showed that both porous PMMA and
porous PMMA-HA supported bone repair. Neither of the bone cements caused
significant inflammation to nerve or other surrounding tissues. After implantation of
12 weeks, majority of the porosity was filled with newly formed bone for both
cements, which supports the concept that a porous structure within PMMA can
enhance bone ingrowth. Histomorphometrical evaluation, using histological grading
scales, demonstrated that, at both 4 week and 12 weeks of implantation time, the
presence of HA in the PMMA enhanced bone formation. The PMMA-HA cement
supported osteoconductivity into the cement porosity and a direct bone-to-cement
contact. Bone was always in direct contact with the HA particles, while intervening
fibrous tissue was present at the PMMA-bone interface. Therefore, this chapter
clearly confirmed that the injectable porous PMMA-HA might be a good candidate
for craniofacial bone repair in clinic.
Due to the fast development of biomaterials, numerous novel hydrogels are used in
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bone tissue engineering. In &KDSWHU , a new porous PMMA/CaP system consisting
of PMMA/chitosan(CS)-glycerophosphate(GP) thermosensitive hydrogel/nano-HA/
gentamicin(GM) was prepared and evaluated. Specifically, nano-HA was used to
mimic the nano-crystals within bone structure. CS-GP hydrogel and nano-HA were
utilized as pore generator as well as drug carrier. It was shown that CS–GP
thermosensitive hydrogel could effectively create open pores at the surface of the
PMMA cement, which is supposed to facilitate bone tissue ingrowth and to improve
the cement anchorage at the bone–cement interface. Meanwhile, such a hydrogel
effectively decreased the maximum polymerization temperature to below 30 ć,
prolonged the working time to more than 720 s and produced cement with a proper
modulus of elasticity and a compressive yield strength ranging from 402 to 584 MPa
and from 3.1 to 5.9 MPa, respectively. Furthermore, the incorporated nano-HA
particles sufficiently increased the mineralization capacity of the cement without
compromising its mechanical properties and the incorporated GM remarkably
enhanced the antibacterial activity of the cement. More importantly, nano-HA and
GM enriched CS–GP thermosensitive hydrogel effectively improved the overall
performance of PMMA cement without influencing cell survival, which suggests that
injectable porous PMMA/CS–GP/nano-HA/GM cement holds strong promise for
future application.
 &ORVLQJ UHPDUNV DQG IXWXUH SHUVSHFWLYHV
This thesis optimized step-by-step tporous PMMA/CMC/CaP composite Also in
the last chapter, a new system of porous PMMA/CS–GP/nano-HA/GM was
developed for mineralization as well as anti-bacterial application. The various
studies demonstrated that the porosity within the PMMA cement could easily be
produced and tuned by the incorporation of hydrogels, which showed beneficial
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effect on the decrease of the polymerization temperature, improvement of the
mechanical properties and support of the bone ingrowth. The loaded CaP rendered
PMMA an osteoconductive property and the loaded drug enhanced the antibacterial
activity of PMMA for infection control. Evidently, the added multifunctionality
improved the biological and mechanical performance of PMMA cement, which
offers promise for future bone reconstruction applications. However, several
challenges remain to be addressed in the future studies.
First, it is well known that porosity plays a pivotal role in the behavior of a
biomaterial with a porous structure [2, 3]. The porogen determines the size and
number of generated pores as well as the mechanical characteristics of the
biomaterial, which in turn affects the tissue ingrowth LQ YLYR Although the
synthesized porous PMMA/CaP-based cements in this thesis all revealed
mechanical properties comparable with cancellous bone, the ingrowth of bone,
blood vessels and soft tissue into cements with different porous structures might be
different. Consequently, the stress transfer at the bone-cement interface after
cement implantation LQ YLYR might be different. Furthermore, the degradation rate of
the used hydrogel porogens, e.g. CMC hydrogel and CS-GP hydrogel, can also
affect the resulting porous structure. This aspect has to be further studied to achieve
optimized clinical results of the porous PMMA cements.
Second, drug-delivery system of porous PMMA/CaP based-cement should be
further evaluated in detail. In this thesis, only in &KDSWHU , the antibacterial ability
of porous PMMA/CaP-based cement was simply investigated by zone of inhibition
test on the basis of antibacterial drug-loaded CS-GP thermosensitive hydrogel.
However, only such an assessment is not sufficient. The elution characteristics of
the drug from the porous PMMA/CaP based-cement should be evaluated in detail. It
is known that an ideal drug release should show an initial burst release of a high
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amount of antibacterial drug to kill the already invaded bacteria, followed by a low
amount of antibacterial drug release for a prolonged period to prevent the
occurrence of infection [4, 5]. Furthermore, different combinations of drug and
PMMA-based cement will show a different anti-bacterial effect [6, 7]. Therefore,
before clinical translation of the drug delivery system, further studies should focus
on the the exact dose level for treatment as well as prophylaxis.
Third, the porous PMMA cement loaded with millimeter-sized HA showed a good
tissue performance in &KDSWHU . The newly formed bone filled the majority of the
cement porosity in the used rabbit mandibular model. However, the created defect
was not critical sized [8]. The repair of critical-sized bone defects is still challenging
in the fields of orthopaedics and maxillofacial surgery. It is known that both PMMA
and CaP are not intrinsically osteoinductive. Therefore, further study has to focus on
the improvement of the bone-formation activity of porous PMMA/CaP
based-cement in critical-sized or even larger bone defects. The addition of clinically
approved osteogenic agents will trigger bone formation.
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 6DPHQYDWWLQJ
Het materiaal polymethylmethacrylaat (PMMA) heeft heden ten dage vele klinische
toepassingen gevonden als botsubstituut. Over langere tijd hebben klinische
waarnemingen echter laten zien dat het gebruik van PMMA cement ook een aantal
nadelen kent, zoals het risico op infectie, onvoldoende biologische activiteit, het
ontstaan van breuken, en de sterk exotherme hitte reactie die plaatsvindt tijdens het
uitharden. Dit proefschrift richt zich daarom op het aanpassen van PMMA, met als
uiteindelijk doel het klinische gedrag te kunnen verbeteren. Voor dit doel, wordt
in +RRIGVWXN  eerst een algemene introductie gegeven over botdefecten, en het
modificeren van PMMA. Tenslotte worden de doelen van het proefschrift bondig
besproken.
Om de bovengenoemde tekortkomingen van PMMA te overwinnen, kunnen diverse
toevoegingen aan het materiaal gedaan worden. Deze toevoegingen kunnen de
nadelen van puur PMMA, zoals in de laatste decennia uitgebreid zijn beschreven,
dan teniet doen. +RRIGVWXN  geeft een overzicht van alle dergelijke additieven.
Het hoofdstuk had verder tot doel informatie te geven over toekomstige toepassing
van PMMA in orthopedische chirurgie, met een specifieke nadruk op aanpassingen
voor de meest algemene klinische complicaties zoals aseptische loslating, infectie
van de prothese, en thermische necrose aan het omliggend weefsel. Er worden in
het algemeen zes typen additieven toegevoegd aan PMMA cement om de
prestaties te kunnen verbeteren, te weten: 1) biokeramiek; 2) vulmaterialen; 3)
antibiotica; 4) poriemakers (porogenen), 5) biologische additieven, en 6) een mix
van diverse toevoegingen. Een mix van diverse toevoegingen lijkt daarbij de meest
toepasselijke keuze, waarbij dan getracht kan worden om een multifunctioneel
cement te ontwikkelen, dat in één keer aan alle klinische vereisten kan voldoen. In
diverse studies is de toegevoegde waarde van poreus PMMA al bewezen, ten
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aanzien van het ingroeien van botweefsel, als drager voor de afgifte van medicijnen,
en als afstandshouder op het gebied van reconstructieve chirurgie. Tenslotte zou
verder gewerkt kunnen worden aan de selectie van doelmatige additieven om de
functie van poreus PMMA cement te optimaliseren voor een aantal specifieke
toepassingen.
De volgende hoofdstukken van het proefschrift waren gericht op het bestuderen van
het gedrag van op poreus PMMA/calcium fosfaat (CaP) gebaseerde cementen,
zowel LQ YLWUR als LQ YLYR.
+RRIGVWXN  beschouwde of CaP partikels in poreus PMMA opgenomen konden
worden, en hoe zulke partikels de bulk fysisch-chemische eigenschappen en
bio-activiteit van het cement beïnvloedden, onder gesimuleerde fysiologische
omstandigheden. Deze studie liet zien dat carboxymethylcellulose (CMC) hydrogel
gebruikt kan worden voor het creëren van porositeit en interconnectiviteit, en verder
dat het toevoegen van CaP geen invloed had op de parameters die te maken
hebben met porositeit, noch op de chemische samenstelling of de mechanische
eigenschappen van het PMMA. Wanneer de cementen werden ondergedompeld in
een omgeving van nagebootste lichaamsvloeistof (simulated body fluid, SPF),
waren de CaP partikels in de poreuze fase in staat om interactie aan te gaan met de
omgeving, en de potentiële bioactiviteit van de cementen te verhogen. De
mechanische eigenschappen werden daarbij niet significant veranderd door het
percentage CaP, of door de incubatie tijd.
In een eerdere studie [1], werd gespeculeerd dat de grootte van de CaP partikels
ook van invloed zou kunnen op het uiteindelijke LQ YLYR gedrag van PMMA/CaP
cement. Om de bot compatibiliteit van poreus PMMA/CaP cement dus verder te
kunnen optimaliseren, werden in +RRIGVWXN  twee CaP keramieken van
verschillende grootte geladen in het PMMA. De fysisch-chemische eigenschappen
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van de cementen werden daarbij geëvalueerd, evenals de capaciteit tot
mineraliseren. Er werd in de studie gevonden dat zowel kleine CaP deeltjes van
enige micrometer, als ook grotere CaP deeltjes van enige millimeter, succesvol aan
het PMMA toegevoegd konden worden. Daarna kon in het cement een
aaneengesloten porositeit verkregen worden door te mixen met CMC. Het
toevoegen van CaP partikels had geen invloed op de maximale polymerisatie
temperatuur van het poreuze PMMA, maar liet wel een reductie zien ten aanzien
van de porositeit, en de gemiddelde porie grootte. Beide typen CaP partikels
zorgden voor een verhoging van de mineralisatie capaciteit van het PMMA cement,
zonder daarbij de mechanische eigenschappen aan te tasten, wat wederom werd
aangetoond na onderdompeling in SBF. De kleinere micrometer CaP partikels
vormden agglomeraten in de poriën van het PMMA, terwijl de grotere millimeter
CaP partikels gedeeltelijk ingebed lagen in de PMMA matrix en gedeeltelijk bloot
lagen in de poriën, wat potentieel botcontact mogelijk zou maken.
In +RRIGVWXN , werden de effecten van de millimeter grootte CaP partikels en het
CMC porogeen, zoals opgenomen in PMMA, verder geëvalueerd ten aanzien van
zowel de bulk fysisch-chemische eigenschappen als van de potentiële bioactiviteit.
Er werd daarbij aangetoond dat het incorporeren van CMC hydrogel leidde tot een
verlaging van de maximum temperatuur van het cement tijdens het uitharden tot
aan de normale lichaamstemperatuur, en tot een verlenging van de tijd om het
cement te kunnen hanteren. Verder werd aangetoond dat de hoeveelheid CMC
verantwoordelijk was voor het creëren van de porositeit en interconnectiviteit, wat
op zijn beurt weer bepalend was voor de uiteindelijke mechanische eigenschappen
van het cement. Het was daarbij interessant dat een verhoging van het aantal CaP
partikels ook zorgde voor een verhoging van de biomineralisatie van het composiet,
zonder dat daarbij de mechanische eigenschappen verslechterden.
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De prestaties van het geoptimaliseerde poreuze PMMA composiet, zoals
ontwikkeld in de bovengenoemde LQ YLWUR studies, werden vervolgens in +RRIGVWXN
 ook LQ YLYR bepaald. In dit hoofdstuk, werden poreus PMMA cement, en poreus
PMMA cement geladen met een hoge hoeveelheid millimeter-groote HA partikels
(PMMA-HA), en vervolgens vergeleken in een mandibulair defect model in het
konijn. Het locale weefselgedrag, het herstel van het botdefect, en de botingroei in
de porositeit van de PMMA implantaten werden met behulp van histologisch
onderzoek geëvalueerd op de tijdstippen 4 en 12 weken na implantatie. De
resultaten lieten zien dat zowel poreus PMMA als poreus PMMA-HA het botherstel
ondersteunden. Geen van beide botcementen leidde tot een significante
ontstekingsreactie in de omliggende weefsels. Aan het einde van de 12 weken
implantatie periode, was bij beide cementen het grootste deel van de porositeit
gevuld met nieuw gevormd botweefsel, wat de gedachte onderschrijft dat een
poreuze structuur in PMMA het ingroeien van bot kan bevorderen.
Histomorfometrische evaluatie, met het gebruik van een histologische puntenschaal,
liet echter zien dat de aanwezigheid van HA in het PMMA de botvorming verhoogde,
zowel op het 4 weeks als op het 12 weeks tijdspunt. Het PMMA-HA cement
ondersteunde de osteoconductiviteit in de cement porositeit, en zorgde voor een
direct contact tussen bot en cement. Bot werd altijd in direct contact met de HA
partikels gezien, terwijl er op het grensvlak tussen PMMA en bot altijd sprake was
van een tussenliggende laag van bindweefsel. Dit hoofdstuk kon dus duidelijk
bevestigen dat het injecteerbare poreuze PMMA-HA een goed kandidaat materiaal
zou zijn, om door te ontwikkelen voor klinische toepassingen in craniofaciaal bot
herstel.
Dankzij de snelle ontwikkelingen op het gebied van de biomaterialen, worden er
tegenwoordig ook diverse nieuwe hydrogelen gebruikt in bot weefsel regeneratie.
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In +RRIGVWXN , werd een nieuw poreus PMMA/CaP system gemaakt en
geëvalueerd, wat bestond uit PMMA/chitosan(CS)-glycerofosfaat(GP)
thermosensitieve hydrogel/nano-HA/ gentamicine (GM). De nano-HA werd specifiek
toegepast om de nano-kristallen uit de natuurlijke botstructuur na te
bootsen. CS-GP hydrogel en nano-HA dienden daarnaast zowel als porogeen, als
voor het afgeven van medicijnen. Er werd aangetoond dat de CS–GP
thermosensitieve hydrogel zeer effectief was voor het creëren van een open
porositeit aan het oppervlak van het PMMA cement, wat waarschijnlijk kan zorgen
voor het ingroeien van botweefsel en een goede hechting op het grensvlak tussen
bot en cement. Tegelijkertijd zorgde het gebruik van de hydrogel voor een verlaging
van de maximale polymerisatie temperatuur tot onder de 30ć, een verlenging van
de verwerkingstijd hoger dan 720 s, en een uiteindelijk cement met de juiste
elasticiteitsmodulus en compressie sterkte, die respectievelijk lag tussen 402-584
MPa en 3.1-5.9 MPa. De ingesloten nano-HA partikels zorgden verder voor een
adequate verhoging van de capaciteit tot mineralisatie, zonder afbreuk te doen aan
de mechanische eigenschappen. Het toegevoegde GM zorgde voor een
aanzienlijke antibacteriële activiteit. Er werd ook vastgesteld dat de CS–GP
thermosensitieve hydrogel met toevoeging van nano-HA en GM de prestaties van
het PMMA cement konden verbeteren, zonder daarbij celgroei te beïnvloeden.
Deze resultaten samen genomen, leidden tot de conclusie dat een injecteerbaar
poreus PMMA/CS–GP/nano-HA/GM cement veelbelovend is voor verdere klinische
toepassing.
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 $IVOXLWHQGH RSPHUNLQJHQ HQ WRHNRPVWSHUVSHFWLHI
In dit proefschrift werd stap voor stap een poreus PMMA/CMC/CaP composiet
geoptimaliseerd. Verder werd er in het laatste hoofdstuk een nieuw poreus
PMMA/CS–GP/nano-HA/GM systeem voor mineralisatie en antibacteriële
toepassingen ontwikkeld. Tezamen toonden deze studies aan dat het eenvoudig
was om een gewenste porositeit te maken in PMMA cement door het toevoegen
van een hydrogel. Een dergelijke toevoeging had gunstige effecten op het verlagen
van de polymerisatie temperatuur, het verbeteren van de mechanische
eigenschappen, en het ondersteunen van het ingroeien van botweefsel. Het
geladen CaP zorgde voor botgeleidende eigenschappen, en de toegevoegde
medicijnen konden zorgen voor een antibacteriële activiteit ter controle van infecties.
Het lijkt daarmee duidelijk dat multifunctionele toevoegingen de biologische en
mechanische prestaties van het PMMA cement duidelijk verbeteren, wat het
materiaal veelbelovend maakt voor toekomstige toepassingen in botweefsel herstel.
Er blijven echter zeker ook uitdagingen over voor vervolgstudies. Ten eerste is het
bekend dat de porositeit een bepalende rol speelt bij het gedrag van een
biomateriaal [2, 3]. Het porogeen bepaalt het aantal en de grootte van de poriën, de
mechanische eigenschappen, en daarmee ook de mogelijkheid to het ingroeien van
weefsel LQ YLYR. Alhoewel alle gesynthetiseerde poreuze PMMA/CaP cementen in
dit proefschrift mechanische eigenschappen hadden die overeen kwamen met
spongieus bot, zal de ingroei van bot, bloedvaten, en zacht weefsel in het cement
toch verschillen bij verschillende porie grootte. Een gevolg daarvan is, dat het
overdragen van belasting op het grensvlak na implantatie eveneens zou kunnen
verschillen. Verder kan de mate van degradatie van de verschillende hydrogelen
(CMC en CS-GP) ook bepalend zijn voor de verkregen poreuze structuur. Zulke
aspecten zouden verder onderzocht moeten worden om echt tot optimale klinische
resultaten te kunnen komen met een poreus PMMA cement.
Ten tweede zou de afgifte van medicijnen vanuit poreuze PMMA/CaP cement
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systemen in detail uitgezocht moeten worden. In dit proefschrift werd in hoofdstuk 7
de activiteit van poreus PMMA/CaP cement onderzocht, met een antibacteriële
toevoeging aan de CS-GP thermosensitieve hydrogel. Deze bepalingen werden
echter alleen op eenvoudige wijze gedaan aan de hand van een zgn. zone
inhibitie experiment. Een dergelijke bepaling is natuurlijk niet voldoende. Het
patroon waarmee het medicijn vanuit het poreuze PMMA/CaP cement vrijkomt zou
in detail onderzocht moeten worden. Het is namelijk bekend dat het ideale patroon
zou moeten bestaan uit een onmiddellijke en sterke vrijgave van een hoge dosis
antibacteriële medicijnen om een bestaande bacteriële infectie te kunnen bestrijden;
gevolgd door een lagere afgifte gedurende langere tijd om een nieuwe infectie te
voorkomen [4, 5]. Vervolgens zouden ook verschillende combinaties van medicijnen
gebruikt kunnen worden, om het antibacteriële effect verder te versterken [6, 7].
Voordat klinische vertaling van een system voor het vrijgeven van medicijnen echt
mogelijk is, moeten studies zich tenslotte toespitsen op het bepalen van de exacte
dosering voor toepassingen bij het bestrijden van een infectie, zowel als bij
toepassingen voor het voorkomen van het ontstaan een infectie.
Als derde punt kan gesteld worden, dat er in hoofdstuk 6 gevonden is dat het
poreuze PMMA cement, wat geladen was met millimeter-grootte HA, goed voldeed.
De porositeit bleek steeds vrijwel in zijn geheel gevuld met nieuw gevormd bot in
het gebruikte mandibulaire defect model. Het toegepaste defect was echter niet van
kritische grootte [8]. Het herstel van botdefecten van kritische grootte is nog steeds
uitdagend bij orthopedische en maxillofaciale chirurgie. Het is bekend dat PMMA en
CaP niet van zichzelf osteoinductief zijn. Daarom zouden verdere studies zich ook
kunnen richten op het verbeteren van de botvormende activiteit van poreus
PMMA/CaP cement in botdefecten van kritische, of zelfs grotere afmetingen. Het
toevoegen van klinisch toegestane osteogene middelen zou daarbij de botvorming
in gang kunnen zetten.
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